Clinical Trial Resource Center


Therapeutic Areas: Oncology | Hematology | Musculoskeletal

Leukemia Clinical Trials


A listing of Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Birmingham : University of Alabama at Birmingham

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Birmingham : Research Site

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Birmingham : University of Alabama Comprehensive Cancer Center University of Alabama

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Birmingham : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Birmingham : Children's Hospital of Alabama Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Birmingham : Children's Hospital of Alabama / University of Alabama at Birmingham

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Birmingham : University of Alabama at Birmingham

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Huntsville : TG Therapeutics Investigational Trial Site

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Mobile : USA Mitchell Cancer Institute

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Muscle Shoals : Northwest Alabama Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Muscle Shoals : Northwest Alabama Cancer Center, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Tuscaloosa : DCH Health System

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Alaska

Anchorage : Alaska Clinical Research

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Arizona

Glendale : Palo Verde Hematology Oncology

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Glendale : Arizona Center for Cancer Care

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Phoenix : US Oncology - Arizona Oncology Associates, PC - HAL - Phoenix

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Scottsdale : Mayo Clinic

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Scottsdale : US Oncology - Arizona Oncology Associates, PC - HAL - Scottsdal

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Scottsdale : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Scottsdale : Mayo Clinic Scottsdale-Phoenix

Patients are needed to participate in a clinical research study of EPZ-5676

Scottsdale : Mayo Clinic Arizona

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Sedona : Arizona Oncology Associates, PC - NAHOA

A clinical research study for the treatment of Chronic Myeloid Leukemia

Tucson : Arizona Oncology Associates, PC - HOPE

A clinical research study for the treatment of Chronic Myeloid Leukemia

Tucson : Arizona Oncology Associates

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Tucson : US Oncology - Arizona Oncology Associates - Carondelet

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tucson : US Oncology - Arizona Oncology Associates - Rudasill

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tucson : Site Reference ID/Investigator# 52902

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Tucson : Site Reference ID/Investigator# 96748

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Tucson : University of Arizona Cancer Center

A Phase 3 clinical study for patients with AML

Tucson : Arizona Oncology Associates

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Tucson : Arizona Oncology Associates, PC - HOPE

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Arkansas

Fort Smith : St. Edward Mercy Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hot Springs : Genesis Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Hot Springs : Genesis Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hot Springs : Genesis Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Jonesboro : NEA Baptist Clinic

A clinical research study for the treatment of Chronic Myeloid Leukemia

Jonesboro : Clopton Clinic of Jonesboro Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Jonesboro : NEA Baptist Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Little Rock : Little Rock Hematology Oncology Associates

A clinical research study for the treatment of Chronic Myeloid Leukemia

Little Rock : US Oncology - Hematology Oncology Services of Arkansas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Little Rock : Little Rock Hematology Oncology Associates, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Little Rock : Hematology Oncology Services of Arkansas SC

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

California

Anaheim : Pacific Cancer Medical Center, Inc

A clinical research study for the treatment of Chronic Myeloid Leukemia

Anaheim : Pacific Cancer Medical Center, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Anaheim : Pacific Cancer Medical Center

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Phase Chronic Myeloid Leukemia

Anaheim : Pacific Cancer Medical Center Inc

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Anaheim : Pacific Cancer Medical Center Inc.

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

BellFlower : Southern California Permanente Medical Group

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Berkeley : Alta Bates Summit Comprehensive Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Burbank : East Valley Hematology and Oncology Medical Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Campbell : Southbay Oncology Hematology Partners

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Carlsbad : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Concord : Bay Area Cancer Research Dept.ofBayAreaCancerResearch

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Concord : Bay Area Cancer Research Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Corona : Compassionate Cancer Care Medical Group (Corona)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Duarte : City Of Hope Medical Center

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

Duarte : Site Reference ID/Investigator# 112875

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Duarte : City of Hope

A Phase 1/Phase 2 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Duarte : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Duarte : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Duarte : City of Hope National Medical Center

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Escondido : Southwest Cancer Care Medical Group

A clinical research study for the treatment of Chronic Myeloid Leukemia

Escondido : California Cancer Associates for Research and Excellence (cCare)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fountain Valley : Compassionate Cancer Care Medical Group CCCMG

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Fountain Valley : Compassionate Cancer Care Medical Group Dept.ofCCCMG-Riverside

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Fountain Valley : Pacific Coast Hematology/Oncology Medical Group, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fountain Valley : Robert A. Moss, M.D. FACP, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fountain Valley : Lalita Pandit, MD, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fullerton : Virginia K. Crosson Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fullerton : St. Jude Heritage Healthcare Virginia K. Crosson Cancer Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Glendora : Wilshire Oncology Medical Group, Inc

A clinical research study for the treatment of Chronic Myeloid Leukemia

Highland : Beaver Medical Group, L.P.

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

La Jolla : Moores Cancer Center, UCSD

A clinical research study of A6 for the treatment of Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, CLL or SLL

La Jolla : UCSD, Division of Blood and Marrow Transplantation, Moores Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Lymphocytic Leukemia or Adult Lymphoblastic Lymphoma

La Jolla : University of California, San Diego

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or CLL

La Jolla : Scripps Cancer Center

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Leukemia

La Jolla : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

La Jolla : Moores Cancer Center UCSD

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

La Jolla : Site Reference ID/Investigator# 48325

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

La Jolla : Site Reference ID/Investigator# 91793

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

La Jolla : Updated

A clinical trial to evaluate treatments using Chlorambucil, GDC-0199 and Obinutuzumab for patients with Chronic Lymphocytic Leukemia

La Jolla :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

La Jolla : Univ. of San Diego: Moores UCSD Cancer Center

A clinical trial to evaluate treatments using GNKG168 for patients with Leukemia

La Jolla : UCSD Moores Cancer Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

La Jolla : UC San Diego Moores Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

La Jolla : Investigational Drug Services - UC San Diego Moores Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

La Jolla : UC San Diego Medical Center - La Jolla

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

La Jolla : University of California San Diego

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

La Jolla : UC San Diego Moores Cancer Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

La Jolla : UCSD Medical Center / Thornton Hospital

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

La Jolla : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

La Jolla : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

La Jolla :

Patients are needed to participate in a clinical research study evaluating GDC-0199 (ABT-199) and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic

La Jolla : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

La Jolla : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

La Jolla : Scripps Cancer Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Loma Linda : Loma Linda University Health Oncology Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Long Beach : Pacific Shores Medical Group

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Los Angeles : University of Southern California

A clinical research study for the treatment of Chronic Myeloid Leukemia

Los Angeles : University of California at Los Angeles Oncology

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Los Angeles : Childrens Hospital Los Angeles

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Los Angeles : Cedars-Sinai Medical Center

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

Los Angeles : UCLA Division of Hematology-Oncology

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Los Angeles : Children's Hospital Los Angeles Updated

A clinical trial to evaluate treatments using BPX-501 T cells and AP1903 for patients

Los Angeles : Research Site

A clinical trial to evaluate treatments using CAT-8015 (Moxetumomab Pasudotox) for patients with Pediatric Acute Lymphoblastic Leukemia (pALL)

Los Angeles : Cedars-Sinai Medical Center

A clinical trial to evaluate treatments using CC-115 for patients

Los Angeles : UCLA

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Los Angeles : USC/Norris Comprehensive Cancer Center /Investigational Drug Services

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : Children's Center for Cancer and Blood Diseases, Childrens Hospital Los Angeles

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : Keck Hospital of USC

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : LAC & USC Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : UCLA Ronald Reagan Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : USC/Norris Comprehensive Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : UCLA Hematology/Oncology Clinic

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : USC/Norris Comprehensive Cancer Center, Investigational Drug Service

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Los Angeles : UCLA

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Los Angeles : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Los Angeles : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Los Angeles : Usc/Norris Comprehensive Cancer Center

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Los Angeles : UCLA Medical Center

A Phase 3 clinical study for patients with AML

Los Angeles : Updated

Patients are needed to participate in a clinical research study evaluating RO5503781 and cytarabine for the treatment of Myelogenous Leukemia, Acute

Los Angeles : Sanguine Biosciences

Patients are needed to participate in a clinical research study for the treatment of All Diagnosed Health Conditions

Los Angeles : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Los Angeles : Metropolitan Hematology Oncology Medical Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Los Angeles : UCLA Ronald Reagan Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Los Angeles : Childrens Hospital Los Angeles

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Madera : Children's Hospital Central California Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Monterey : Monterey Bay Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Northridge : West Valley Hematology Oncology Medical Group

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Oceanside : North County Oncology

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Oceanside : North County Oncology

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Orange : UC Irvine Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Orange : Children's Hospital of Orange County

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Orange : Children's Hospital of Orange County CHOC

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Orange : University of California, Irvine Updated

A Phase 2 clinical study for patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Orange : Children's Hospital of Orange County Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Orange : Children's Hospital of Orange County

Patients are needed to participate in a clinical research study of pegcrisantaspase to evaluate Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

Orange : Children's Hospital Orange County

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Oxnard : PMK Medical Group, Inc. DBA Ventura

A clinical research study for the treatment of Chronic Myeloid Leukemia

Oxnard : Ventura County Hematology Oncology Specialists

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Palo Alto : Updated

A clinical research study of cytarabine and vismodegib for the treatment of Myelodysplastic Syndromes, Myelogenous Leukemia, Acute

Palo Alto : Stanford University Medical Center

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Palo Alto : Stanford University Hospital and Clinics - Clinical Translation Research Unit

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Palo Alto : Stanford University Cancer Clinical Trials Office

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Palo Alto :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Palo Alto : Stanford University Medical Center Oncology

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Pismo Beach : PCR Oncology

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Pleasant Hill : Bay Area Cancer Research Group, LLC (BIMAL PATEL)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pleasant Hill : Bay Area Cancer Research Group, LLC (JOHN GANEY)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pleasant Hill : Bay Area Cancer Research Group, LLC (ROBERT ROBLES)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pleasant Hill : Bay Area Cancer Research Group, LLC (OSTAP MELNYK)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Rancho Mirage : Desert Hematology Oncology Medical Group

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Rancho Mirage : Cancer and Blood Institute Medical Group

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Riverside : Compassionate Cancer Care Medical Group (Riverside)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Roseville : Capitol Hematology Oncology Medical Group - Sutter Roseville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sacramento : University of California Comprehensive Cancer Center

A Phase 2 clinical study for patients with Acute Myelogenous Leukemia

Sacramento : University of California Comprehensive Cancer Center

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia

Sacramento : UC Davis Cancer Center

A Phase 3 clinical study for patients with AML

Sacramento : University of California Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Leukemia

Sacramento : University of California Davis

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Myeloid Leukemia or Myelodysplastic Syndrome

San Diego : Rady Children's Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

San Diego : UC San Diego Medical Center - Hillcrest

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

San Diego : Sharp Memorial Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Diego : Kaiser Permanente Medical Group

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

San Diego : UCSD Moores Cancer Research Institute

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

San Francisco : Ucsf Division Of Hematology And Oncology

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

San Francisco : UCSF School of Medicine

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

San Francisco : UCSF Helen Diller Family Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome

San Francisco : University of California at San Francisco

A clinical trial to evaluate treatments using CC-115 for patients

San Francisco : UCSF Helen Diller Family Family Comprehensive Cancer Center

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

San Francisco : University of California San Francisco Medical Center - Parnassus Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

San Francisco : University of California - San Francisco

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

San Francisco : UCSF School of Medicine

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

San Luis Obispo : Coastal Integrative Cancer Care

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Santa Maria : Central Coast Medical Oncology

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Santa Monica : Sarcoma Oncology Center

A clinical trial to evaluate treatments using NRX 195183 Soft Gelatin Capsule for patients with Acute Promyelocytic Leukemia

Santa Rosa : Redwood Regional Medical Group, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Santa Rosa : St Joseph Heritage Healthcare

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Stanford :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Stanford : Site Reference ID/Investigator# 105117

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Stanford : Stanford University Hospital and Clinics

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Stanford : Stanford Cancer Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Stanford : Stanford University School of Medicine

A clinical trial to evaluate treatments using Lenalidomide for patients with Anemia, Leukemia, Leukemia, Myelocytic, Acute or Dysmyelopoietic Syndromes

Stanford : Site Reference ID/Investigator# 121535

A Phase 2 clinical study for patients with Acute Myelogenous Leukemia, AML or Acute Myeloid Leukemia

Stanford : Stanford University Cancer Institute

A Phase 2 clinical study for patients with Acute Myeloid Leukemia With 11q23-abnormality in Relapse

Stanford : Stanford Cancer Center - Stanford University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Stanford :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Stanford : Stanford Cancer Center

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Stanford : Stanford School of Medicine

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Stockton : St. Teresa Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Thousand Oaks : Ashwin Kashyap MD, INC.

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Vallejo : Kaiser Permanente Medical Center

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Vista : Medical Group of North County

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

West Hills : Wellness Oncology & Hematology

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Whittier : Innovative Clinical Research Institute

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Whittier : Innovative Clinical Research Institute

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Whittier : The Oncology Institute of Hope and Innovation

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Whittier : Innovative Clinical Research Institute

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Colorado

Aurora : Site Reference ID/Investigator# 127859

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Aurora : University of Colorado Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Aurora : Children's Hospital Colorado

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Aurora : Children's Hospital Colorado

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Aurora : US Oncology - Rocky Mountain Cancer Center - Aurora

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Aurora : University of Colorado Hospital, Cancer Center Infusion Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Aurora : University of Colorado Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Aurora : University of Colorado Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Aurora : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Aurora :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Aurora : Updated

Patients are needed to participate in a clinical research study of RO6839921 to evaluate Neoplasms, Myelogenous Leukemia, Acute

Aurora : The Children's Hospital, University of Colorado

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Boulder : Rocky Mountain Cancer Centers

A clinical research study for the treatment of Chronic Myeloid Leukemia

Boulder : US Oncology - Rocky Mountain Cancer Center - Boulder

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boulder : Rocky Mountain Cancer Centers, LLP

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Boulder : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Colorado Springs : US Oncology - Rocky Mountain Cancer Center - CO Springs

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Colorado Springs : US Oncology - Rocky Mountain Cancer Center - At the Pavillion

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Colorado Springs : The Oncology Clinic, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Denver : Colorado Blood Cancer Institute/Sarah Cannon Research Institute Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Denver : Sarah Cannon Research Institute

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Denver :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Denver : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Denver : Colorado Blood Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Denver : US Oncology - Rocky Mountain Cancer Center - Rose

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Denver : US Oncology - Rocky Mountain Cancer Center - Midtown

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Denver : The Colorado Blood Cancer Institute

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Denver : Colorado Blood Cancer Institute

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia

Denver :

Patients are needed to participate in a clinical research study evaluating GDC-0199 (ABT-199) and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic

Denver : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Denver : Rocky Mountain Cancer Centers

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Denver : Colorado Blood Cancer Institute

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Denver : Mile High Oncology

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lakewood : US Oncology - Rocky Mountain Cancer Center - Lakewood

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Littleton : US Oncology - Rocky Mountain Cancer Center - Littleton

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lone Tree : US Oncology - Rocky Mountain Cancer Center - Sky Ridge

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Longmont : US Oncology - Rocky Mountain Cancer Center - Longmont

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Parker : US Oncology - Rocky Mountain Cancer Center - Parker

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pueblo : US Oncology - Rocky Mountain Cancer Center - Pueblo

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Thornton : US Oncology - Rocky Mountain Cancer Center - Thornton

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Connecticut

Manchester : Medical Oncology and Blood Disorders, LLP

A clinical research study for the treatment of Chronic Myeloid Leukemia

Manchester : Medical Oncology and Blood Disorders, LLP

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Britain : Hospital of Central Connecticut

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Haven : Smilow Cancer Center at Yale New Haven Hospital (Drug Shipment Address)

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New Haven : Smilow Cancer Center at Yale New Haven Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New Haven : 1230.30.10004 Boehringer Ingelheim Investigational Site Updated

A Phase 1 clinical study for patients with Leukemia, Myeloid, Acute

Norwalk : Norwalk Hospital

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Southington : Cancer Center Of Central Connecticut

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Phase Chronic Myeloid Leukemia

Southington : Cancer Center of Central Connecticut

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Southington : Cancer Center Of Central Connecticut

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Southington : Cancer Center of Central Connecticut

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Southington : Cancer Center of Central Connecticut

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Southington : Cancer Center of Central Connecticut

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Southington : Cancer Center of Central Connecticut

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Stamford : Stamford Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Stamford : Stamford Hospital Med. Oncology Hematology Res.

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Delaware

Newark : Delaware Clinical & Laboratory Physicians, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Newark : Helen F. Graham Cancer Center

A Phase 1/Phase 2 clinical study for patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

District of Columbia

Washington : Children's National Medical Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Washington : Site Reference ID/Investigator# 96954

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Washington : Georgetown University

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Washington : Site Reference ID/Investigator# 127261

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Washington : Children's National Medical Center Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Washington : Children's National Medical Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Florida

Altamonte Springs : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Altamonte Springs : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Atlantis : Medical Specialists of the Palm Beaches

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boca Raton : Boca Raton Community Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Bonita Springs : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Bonita Springs : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boynton Beach : University Cancer Institute

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Boynton Beach : Hematology And Medical Oncology Of Southern Palm Beach County

A clinical research study for the treatment of Chronic Myeloid Leukemia

Boynton Beach : University Cancer Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boynton Beach : Collaborative Research Group

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Boynton Beach : Palm Beach Institute of Hematology and Oncology

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Bradenton : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Bradenton : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Brandon : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Brandon : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Brooksville : Pasco Hernando Oncology Associates, PA

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Cape Coral : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Cape Coral : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clearwater : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Clearwater : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Englewood : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Fort Lauderdale : Broward Oncology Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Myers : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Fort Myers : Lee Memorial Health System Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Fort Myers : Florida Cancer Specialists-South

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia

Fort Myers : Florida Cancer - Colonial

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Fort Myers : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Gainesville : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Gainesville : Florida Cancer Specialists & Research Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Gainesville : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Gainesville : Shands Cancer Hospital at University of Florida

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Hialeah : Palm Springs Research Institute

A clinical research study for the treatment of Chronic Myeloid Leukemia

Hollywood : Memorial Healthcare System

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Hollywood : Memorial Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Hollywood : Memorial Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Hudson : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Hudson : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Inverness : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Inverness : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Jacksonville : Cancer Specialists of North Florida

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Jacksonville : University Of Florida

A clinical research study for the treatment of Chronic Myeloid Leukemia

Jacksonville : Baptist Cancer Institute

A clinical research study for the treatment of Chronic Myeloid Leukemia

Jacksonville :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Jacksonville : Mayo Clinic Jacksonville

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Jacksonville : University of Florida College of Medicine - Jacksonville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Jacksonville : Cancer Specialists of North Florida

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Jacksonville : Baptist Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Jacksonville : Mayo Clinic - Jacksonville

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Jacksonville : Integrated Community Oncology Network

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Jacksonville : Mayo Clinic Florida

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Kissimmee : Osceola Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lake City : Cancer Care of North Florida, P.A. Cancer Care - Lake City, FL (2

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Lakeland : Watson Clinic Center for Cancer Care and Research

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Lakeland : Watson Clinic

A clinical research study for the treatment of Chronic Myeloid Leukemia

Lakeland : Watson Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Largo : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Largo : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Lecanto : Cancer & Blood Disease Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Miami : University of Miami Cancer Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Miami : University of Miami / Sylvester Comprehensive Cancer Center

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

Miami : Miami Children's Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Miami :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Miami :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Miami : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Miami : University of Miami Cancer Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Naples : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Naples : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

New Port Richey : Florida Cancer Specialists

A clinical research study for the treatment of Chronic Myeloid Leukemia

New Port Richey : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

New Port Richey : Florida Cancer Specialists

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Port Richey : Pasco Hernando Oncology Associates (Kumar)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Port Richey : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

New Port Richey : Pasco Hernando Oncology Associates, PA

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

New Port Richey : Pasco Pinellas Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Orange City : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Orange City : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Orlando : Cancer Centers of Florida

A clinical research study for the treatment of Chronic Myeloid Leukemia

Orlando : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Orlando : Nemours Children's Hospital Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Orlando : MD Anderson Cancer Center Orlando - 5th Floor Investigational Pharmacy

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Orlando : Orlando Heart Health Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Orlando : Orlando Regional Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Orlando : M.D. Anderson Cancer Center Orlando

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Orlando : MD Anderson Cancer Center Orlando

A Phase 1/Phase 2 clinical study for patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Orlando : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Orlando : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Pensacola : Sacred Heart Medical Oncology Group

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Pensacola : Sacred Heart Medical Oncology Group

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Port Charlotte : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Port Charlotte : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Port St. Lucie : Hematology Oncology Associates of the Treasure Coast

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Rockledge : Cancer Care Centers of Brevard

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Rockledge : Cancer Care Centers of Brevard

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sarasota : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Sarasota : Florida Cancer Specialists-South

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Sarasota : Florida Cancer Specialists

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Sarasota : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Sarasota : Florida Cancer Specialists/Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating PRT062070 for the treatment of Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or B-cell Non Hodgkin Lymphoma (NHL)

Spring Hill : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Spring Hill : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

St. Petersburg : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

St. Petersburg : Florida Cancer Specialists-North

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

St. Petersburg : Florida Cancer Specialists-North

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia

St. Petersburg : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

St. Petersburg : All Children's Hospital

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Tampa : H. Lee Moffitt Cancer Center & Research Institute Oncology

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Tampa : H. Lee Moffitt Cancer Center and Research Institute Updated

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

Tampa : H. Lee Moffitt Cancer Center and Research Institute

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Tampa : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Tampa : Moffitt Cancer Center & Research Institute

A clinical trial to evaluate treatments using CC-115 for patients

Tampa : Moffitt Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Tampa : H. Lee Moffitt Cancer Center & Research Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Tampa : H. Lee Moffitt Cancer Center & Research Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Tampa :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Tampa : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Tampa : H. Lee Moffitt Cancer Center

A Phase 2 clinical study for patients using Plerixafor

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Patients are needed to participate in a clinical research study evaluating CNDO-109-AANK Cells for the treatment of Acute Myeloid Leukemia

Tampa : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Tampa : H. Lee Moffitt Cancer Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Tampa : H. Lee Moffitt Cancer Center and Research Institute

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Tampa : H. Lee Moffitt Cancer Center & Research Institute

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Tampa : H. Lee Moffitt Cancer Center and Research Institute Updated

Patients are needed to participate in a clinical research study to evaluate Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Tavares : Lake County Oncology and Hematology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Tavares : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Tavares : Lake County Oncology & Hematology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tavares : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Titusville : Space Coast Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Venice : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Venice : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

West Palm Beach : St. Mary's Hospital Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Weston : Cleveland Clinic Florida

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Georgia

Albany : Phoebe Putney Memorial Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Piedmont Cancer Institute, P.C. (was Peachtree Hematology-Oncology Consultants)

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Atlanta : Emory University

A clinical research study for the treatment of Chronic Myeloid Leukemia

Atlanta : Winship Cancer Institute

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Atlanta : Emory University, Winship Cancer Institute

A clinical research study of eltrombopag olamine and standard follow-up care

Atlanta : Children's Healthcare of Atlanta, Emory University

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Atlanta : Northside Hospital

A clinical trial seeking patients for a research study of MLN9708

Atlanta : Children's Healthcare of Atlanta

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Atlanta : Winship Cancer Institute

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Atlanta : Georgia Cancer Specialists

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Emory University

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Peachtree Hematology-Oncology Consultants

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Atlanta : Blood and Marrow Transplant Group of Georgia

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Atlanta : The Emory Clinic

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Atlanta : Winship Cancer Institute, Emory University

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Atlanta : Emory University Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Atlanta : Northside Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Atlanta : Emory University Clinic - Investigational Drug Service

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Atlanta : Emory University, Winship Cancer Institute

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Atlanta : Winship Cancer Institute, Emory University

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Atlanta : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Atlanta : Emory University

A Phase 2 clinical study for patients using Plerixafor

Atlanta : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Atlanta : Emory Winship Cancer Institute

A Phase 3 clinical study for patients with AML

Atlanta : Children's Healthcare of Atlanta-Egleston Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Atlanta : Northside Hospital

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Atlanta : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Atlanta : Winship Cancer Institute, Emory University

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Atlanta : Blood and Marrow Transplant Group of Georgia

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Atlanta : Children's Healthcare of Atlanta / Emory University

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Atlanta : Children's Healthcare of Atlanta, Emory University

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Augusta : For additional information regarding sites for this trial call (919) 465-4648

A clinical research study of 20 mg/kg TRU-016 + Rituximab, 10 mg/kg TRU-016 + Rituximab and TRU-016 20 mg/kg + Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

Augusta : Georgia Health Sciences University

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Augusta : Georgia Regents University Augusta - Div. of Hematology/Oncology - BMT

Patients are needed to participate in a clinical research study evaluating PGX-ODSH-2013-AML-1 for the treatment of Acute Myeloid Leukemia

Augusta : Augusta Oncology Associates, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Dublin : US Oncology - Dublin Hematology & Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Griffin : Spalding Oncology Services

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lawrenceville : Gwinnett Hospital System Dba The Center for Cancer Care

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Marietta : Northwest Georgia Oncology Centers, P.C.

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Marietta : Northwest Georgia Oncology Centers, PC

A clinical research study for the treatment of Chronic Myeloid Leukemia

Marietta : Northwest Georgia Oncology Centers, P.C.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Marietta : Northwest Georgia Oncology Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Sandy Springs : Georgia Cancer Specialist

A clinical research study for the treatment of Chronic Myeloid Leukemia

Thomasville : Lewis Hall Singletary Oncology Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hawaii

Honolulu : Straub Clinical & Hospital

A clinical research study for the treatment of Chronic Myeloid Leukemia

Honolulu : OnCare

A clinical research study for the treatment of Chronic Myeloid Leukemia

Honolulu : Straub Clinic and Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Honolulu : Kaiser Permanente Hawaii Moanalua Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Idaho

Boise : Saint Alphonsus Regional Medical Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Boise : St Luke's Mountain States Tumor Institute

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Illinois

Arlington Heights : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Arlington

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : Northwestern University Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Chicago : University of Chicago Medicine Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Chicago : Site Reference ID/Investigator# 128742

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Chicago : Northwestern University

A clinical research study of alemtuzumab, ofatumumab and biopsy for the treatment of Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia or Stage IV Chronic Lymphocytic Leukemia

Chicago : Northwestern University Feinberg School Of Medicine

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

Chicago : University of Chicago

A clinical research study of L-asparaginase encapsulated in RBC for the treatment of Acute Lymphoblastic Leukemia

Chicago : University of Chicago Medical Center

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Chicago : Lurie Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Chicago : University of Chicago

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Chicago : Northwestern University

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

Chicago : 1315.1.1003 Boehringer Ingelheim Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

Chicago : Robert H. Lurie Comprehensive Cancer Center of Northwestern University Medical School

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago Dept of Oncology Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Chicago : Northwestern University Feinberg School of Medicine

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Chicago : Rush University Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Chicago : University of Chicago Cancer Research Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Chicago : John H. Stroger, Jr., Hospital of Cook County

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : Northwestern Univ and Robert H. Lurie Comprehensive Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : Rush University Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chicago : Site Reference ID/Investigator# 96960

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Chicago : Site Reference ID/Investigator# 92499

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Chicago : The University of Chicago

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Chicago : The University of Chicago Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Chicago : Northwestern Memorial Hospital - Drug Shipment Address

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Chicago : Northwestern Medical Faculty Foundation (NMFF)

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Chicago : Rush University Medical Center, Division of Hematology/Pathology

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Chicago : Northwestern University, Feinberg School of Medicine

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Chicago : Northwestern University

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

Chicago : University of Chicago

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Chicago : Northwestern University Fienberg School of Medicine

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Chicago : Ann & Robert H. Lurie Children's Hospital of Chicago Ann&Robert Lurie

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Chicago : Northwestern University

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago : University of Chicago

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Chicago : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Chicago : University of Chicago

A Phase 2 clinical study for patients using Plerixafor

Chicago : University of Chicago Updated

A Phase 2 clinical study for patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Chicago : University of Chicago

A Phase 3 clinical study for patients with AML

Chicago : Northwestern Medical Faculty Foundation

A Phase 3 clinical study for patients with AML

Chicago :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Chicago : Ann and Robert H. Lurie Children's Hospital of Chicago Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Chicago : Northwestern University Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Chicago : University of Chicago Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Chicago : John H. Stroger, Jr. Hospital of Cook County

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Chicago : Children's Memorial Hospital

Patients are needed to participate in a clinical research study evaluating Extracorporeal Photopheresis for the treatment of Leukemia or Cancer

Chicago : Northwestern University Feinberg School of Medicine

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Chicago : Robert H. Lurie Comprehensive Cancer Center at Northwestern University

Patients are needed to participate in a clinical research study of Autologous tumor cell extract vaccine to evaluate Chronic Lymphocytic Leukemia (CLL)

Chicago : Northwestern University-Robert H. Lurie Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of BL-8040 +Ara-C to evaluate Acute Myeloid Leukemia

Chicago : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Chicago : Northwestern University Feinberg School of Medicine

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Chicago : Northwestern University

Patients are needed to participate in a clinical research study of EPZ-5676

Chicago : Northwestern University

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Chicago : Northwestern Memorial Hospital

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Chicago : The University of Chicago Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Chicago : Rush University Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Chicago : Lurie Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Elk Grove Village : Northwest Oncology & Hematology Cancer Institute

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Evergreen Park : Mahafzah Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Gurnee : Oncology Hematology Assoc. of Northern Illinois

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Harvey : Ingalls Cancer Research Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Harvey : Site Reference ID/Investigator# 92497

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Harvey :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Harvey : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Harvey : Ingalls Memorial Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Hines : Edward Hines Jr. VA Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Lombard : Elmhurst Memorial Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Niles : Orchard Health Care Research

A clinical research study for the treatment of Chronic Myeloid Leukemia

Niles : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Niles

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Niles : Oncology Specialists, S.C.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Niles : Illinois Cancer Specialists

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Normal : Mid-Illinois Hem/Onc Asoc

A clinical research study for the treatment of Chronic Myeloid Leukemia

North Chicago : North Chicago VA Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Peoria : Illinois Cancer Care

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Skokie : Orchard Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Springfield : Southern Illinois School of Medicine

A clinical research study for the treatment of Chronic Myeloid Leukemia

Urbana : Carle Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Urbana : Carle Cancer Center

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Winfield : US Oncology - Cancer Care & Hematology Specialists of Chicagoland - Winfield

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Indiana

Anderson : St. Vincent Anderson Regional Hospital Research

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Anderson : Saint John's Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Bloomington : IU health Bloomington Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Goshen : Center for Cancer Care @ Goshen Health Systems

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Goshen : IU Health Goshen Center for Cancer Care

A Phase 1/Phase 2 clinical study for patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Indianapolis : Indiana Blood and Marrow Transplantation

A clinical research study for the treatment of Chronic Myeloid Leukemia

Indianapolis : Investigative Clinical Research of Indiana

A clinical research study for the treatment of Chronic Myeloid Leukemia

Indianapolis : Indiana Blood and Marrow Transplant

A clinical research study of CDX-301 with or without plerixafor

Indianapolis : Franciscan Saint Francis Health

A clinical research study of CPX-351 for the treatment of Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS)

Indianapolis : Indiana University Melvin and Bren Simon Cancer Center Updated

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Indianapolis : Indiana University Cancer Center Clinical Research Office

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Indianapolis : St. Francis Cancer Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Indianapolis : Franciscan Physician Network Oncology & Hematology

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Indianapolis : Indiana Blood and Marrow Transplantation Clinic

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Indianapolis : Indiana University Riley Hospital for Children

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Indianapolis : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Indianapolis : St. Francis Medical Group Oncology And Hematology Specialist

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Indianapolis : Franciscan Alliance

A Phase 3 clinical study for patients with AML

Indianapolis : Riley Hospital for Children Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Indianapolis : Indiana Blood & Marrow Transplantation

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Indianapolis : Indiana Blood and Marrow Transplantation Clinic Updated

Patients are needed to participate in a clinical research study of CLT-008 and G-CSF to evaluate Acute Myeloid Leukemia

Indianapolis : Indiana Oncology Hematology Consultants

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Indianapolis : St. Francis Medical Group Oncology and Hematology Specialists

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Lafayette : Horizon Oncology Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Lafayette : Arnett Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Mishawaka : Cancer Care Partners, LLC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Albany : Cancer Care Center, Inc. PC

A clinical research study for the treatment of Chronic Myeloid Leukemia

New Albany : Cancer Care Center, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Albany : Cancer Care Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Newburgh : Oncology Hematology Associates of Southwest Indiana

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Westville : Michiana Hematology Oncology, P.C.

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Iowa

Ames : McFarland Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bettendorf : Hematology Oncology Associates of the Quad Cities

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cedar Rapids : Iowa Blood and Cancer Care of PCI

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cedar Rapids : Iowa Blood and Cancer Care of PCI

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Iowa City : University of Iowa Hospitals and Clinics

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Iowa City : University of Iowa Hospitals and Clinics

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Mason City : N. Iowa Mercy Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Sioux City : Siouxland Hematology-Oncology Associates, LLP

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Waterloo : Covenant Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kansas

Fairway : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Hutchinson : Hutchinson Clinic

A clinical research study for the treatment of Chronic Myeloid Leukemia

Kansas City : University of Kansas Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Kansas City : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Overland Park : Kansas City Cancer Center KCCC Business Office

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Topeka : Cotton O'Neil Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Westwood : University of Kansas Cancer Center

A clinical research study of CPX-351 for the treatment of Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL) or Myelodysplastic Syndrome (MDS)

Westwood : University of Kansas Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Westwood : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Westwood : University of Kansas Medical Center Research Institute Inc

A Phase 3 clinical study for patients with AML

Wichita : Cancer Center of Kansas

A clinical research study for the treatment of Chronic Myeloid Leukemia

Wichita : Cancer Center of Kansas, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kentucky

Crestview Hills : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Crestview Hills : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Hazard : Kentucky Cancer Clinic

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Lexington : Central Baptist Hospital

A clinical research study for the treatment of Chronic Myeloid Leukemia

Lexington : University of Kentucky Medical Center

A Phase 1/Phase 2 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Louisville : Norton Cancer Institute

A clinical research study of Ibrutinib, Obinutuzumab and Chlorambucil for the treatment of Chronic Lymphocytic Leukemia (CLL) or Small-Cell Lymphom

Louisville : Norton Cancer Institute, Suburban

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Louisville : Norton Cancer Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Mount Sterling : Montgomery Cancer Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Louisiana

Alexandria : Cabrini Center for Cancer Care

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Baton Rouge : Mary Bird Perkins Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Baton Rouge : Hematology Oncology Clinic, PLLC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Lafayette : Cancer Center of Acadiana at Lafayette General Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

New Orleans : Ochsner Medical Institutions

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Shreveport : Willis-Knighton Cancer System

A clinical research study for the treatment of Chronic Myeloid Leukemia

Maryland

Baltimore : Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Updated

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

Baltimore : Johns Hopkins University

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Baltimore : Sidney Kimmel Cancer Center at Johns Hopkins

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

Baltimore : St. Agnes Healthcare, Inc.

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Phase Chronic Myeloid Leukemia

Baltimore : University of Maryland Baltimore

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Baltimore : The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Baltimore : Johns Hopkins University

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

Baltimore : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Baltimore : University of Maryland

A Phase 3 clinical study for patients with AML

Baltimore : St. Agnes Hospital SC

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Baltimore : University of Maryland Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Baltimore : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Baltimore : Auerbach Hematology Oncology Associates, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Baltimore : Greater Baltimore Medical Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Baltimore : Chesapeake Oncology Hematology Associates

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Baltimore : University of Maryland Greenbaum Cancer Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Baltimore : Johns Hopkins University

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Bethesda : National Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

Bethesda : Center for Cancer and Blood Disorders

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Bethesda : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Bethesda : National Institutes of Health Clinical Center, 9000 Rockville Pike

Patients are needed to participate in a clinical research study of Clofarabine and Lenalidomide

Columbia : Maryland Oncology Hematology Pa

A clinical research study for the treatment of Chronic Myeloid Leukemia

Cumberland : Western Maryland Health System

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Cumberland : Western Maryland Health System, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Massachusetts

Boston : Boston VA Healthcare System

A clinical research study for the treatment of Chronic Myeloid Leukemia

Boston : Site Reference ID/Investigator# 127857

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Boston : Dana Faber Cancer Institute

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Boston : Massachusetts General Hospital Cancer Center

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Boston : Dana Farber

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Boston : Massachusetts General Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Boston : Dana Farber Cancer Institute and Children's Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Boston : Dana-Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boston : Massachusetts General Hospital

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boston : Beth Israel Deaconess Medical Center

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boston : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boston : Dana Farber Cancer Institute

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Boston : Massachusetts General Hospital

A clinical trial seeking patients for a research study for the treatment of Relapsed Acute Myeloid Leukemia or Refractory Acute Myeloid Leukemia

Boston : Dana-Farber Cancer Institute

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Boston : Site Reference ID/Investigator# 48324

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Boston : Site Reference ID/Investigator# 92494

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Boston : Beth Israel Deaconess Medical Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Boston : Massachusetts General Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Boston : Brigham and Women's Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Boston : Dana-Farber Cancer Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Boston : Dana-Farber Cancer Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Boston : Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

Boston : Dana Farber Cancer Institute

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

Boston : DFCI

A clinical trial to evaluate treatments using TG02 citrate for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boston : Massachusetts General Hospital Updated

A Phase 1 clinical study for patients with Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, B-cell Adult Acute Lymphoblastic Leukemia or T-cell Adult Acute Lymphoblastic Leukemia

Boston : Beth Israel Deaconess Medical Center

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia

Boston : Dana Farber Cancer Institute Hematology / Oncology

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Boston : Dana Farber Cancer Institute

A Phase 1 clinical study for patients with Lymphoblastic Leukemia, Acute T-cell or Precursor T-Cell Lymphoblastic Lymphoma

Boston : Dana-Farber Cancer Institute

A Phase 1 clinical study for patients with Relapsed Acute Lymphoblastic Leukemia (ALL), Refractory Acute Lymphoblastic Leukemia (ALL), Relapsed Acute Myelogenous Leukemia (AML) or Refractory Acute Myelogenous Leukemia (AML)

Boston : Boston Children's Hospital

A Phase 1 clinical study for patients with Relapsed Acute Lymphoblastic Leukemia (ALL), Refractory Acute Lymphoblastic Leukemia (ALL), Relapsed Acute Myelogenous Leukemia (AML) or Refractory Acute Myelogenous Leukemia (AML)

Boston : Tufts University School of Medicine

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Boston : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Boston : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Boston : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Boston : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Boston : Massachusetts General Hospital

A Phase 2 clinical study for patients using Plerixafor

Boston :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating Cordycepin plus Pentostatin for the treatment of Refractory TdT-Positive Leukemia

Boston : Brigham & Women's Hospital

Patients are needed to participate in a clinical research study evaluating Cordycepin plus Pentostatin for the treatment of Refractory TdT-Positive Leukemia

Boston : Tufts Medical Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Boston : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating IPI-145, Fludarabine, Cyclophosphamide and Rituximab for the treatment of Chronic Lymphocytic Leukemia

Boston : Dana-Farber Cancer Institute/Brigham and Women's Hospital

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study evaluating TGR-1202 and Ibrutinib for the treatment of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma or Mantle Cell Lymphoma (MCL)

Boston : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Boston : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of Ibrutinib, Fludarabine, Cyclophosphamide and Rituximab to evaluate Chronic Lymphocytic Leukemia

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study of Ibrutinib, Fludarabine, Cyclophosphamide and Rituximab to evaluate Chronic Lymphocytic Leukemia

Boston : Dana-Farber Cancer Institute

Patients are needed to participate in a clinical research study of Idelalisib and Ofatumumab to evaluate Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Boston : Beth Israel Deaconess Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Boston : Boston Children's Hospital

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Boston : Massachusetts General Hospital

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Boston : Dana Farber Cancer Institute

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Boston : Dana Farber

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Burlington : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Hyannis : Capecod Hospital / Davenport Mugar Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Quincy : Commonwealth Hematology-Oncology, P.C.

A clinical research study for the treatment of Chronic Myeloid Leukemia

Worcester : University of Massachusetts Medical School Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Worcester : University of Massachusetts Worcester

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Worcester : University of Massachusetts Worcester

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Worcester : Fallon Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Worcester : University of Massachusetts Worcester

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Worcester : UMass Memorial Cancer Center of Excellence

A Phase 1/Phase 2 clinical study for patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Worcester : University of Massachusetts Worcester

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Worcester : University of Massachusetts Medical School

Patients are needed to participate in a clinical research study of Zileuton (Zyflo®) Dasatinib (Sprycel®), Dosing with Zileuton/Dasatinib in CML, Daily dosing of Zileuton/Dasatinib and Daily dosing with Zileuton/Dasatinib for CML to evaluate Chronic Myelogenous Leukemia

Michigan

Ann Arbor : University of Michigan Comprehensive Cancer Center Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Ann Arbor : Updated

A clinical research study of cytarabine and vismodegib for the treatment of Myelodysplastic Syndromes, Myelogenous Leukemia, Acute

Ann Arbor : C.S. Mott Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Ann Arbor :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Ann Arbor : Site Reference ID/Investigator# 102856

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Ann Arbor : University of Michigan Updated

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Ann Arbor : University of Michigan Health System-

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Ann Arbor : University of Michigan Health System

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Ann Arbor : University of Michigan Comprehensive Cancer Center Onc Dept

A Phase 1 clinical study for patients with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Ann Arbor : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Ann Arbor : University of Michigan Health System

A Phase 3 clinical study for patients with AML

Ann Arbor : C S Mott Children's Hospital Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Ann Arbor : St. Joseph Mercy Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Ann Arbor : University of Michigan Health System

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Ann Arbor : University of Michigan Health System

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Ann Arbor : C.S. Mott Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Bay City : Michigan State University/Bay Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Detroit : Wayne State University/Wertz Clinical Cancer Center Karmanos

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Detroit : Children's Hospital of Michigan

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Detroit :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Detroit : Barbara Karmanos Cancer Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Detroit : Karmanos Cancer Institute

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Detroit : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Detroit : Barbara Ann Karmanos Cancer Institute

A Phase 3 clinical study for patients with AML

Detroit : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Detroit : Karmanos Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Detroit : Henry Ford Health System

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Farmington Hills : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Flint : Genesys Hurley Cancer Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Flint : Michigan State University / McLaren Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Flint : Genesee Cancer & Blood Disease Treatment Center, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Freesoil : West Michigan Regional Cancer & Blood Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Grand Rapids : Cancer and Hematology Centers of Western Michigan

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Grand Rapids : Spectrum Health Hospitals

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Kalamazoo : West Michigan Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Kalamazoo : West Michigan Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lansing : Michigan State University

A clinical research study for the treatment of Chronic Myeloid Leukemia

Lansing : Michigan State University/ Breslin Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lapeer : Michigan State University/ Lapeer Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Mount Clemens : Michigan State University/ Mount Clemens Regional Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Owosso : Michigan State University/ Memorial Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Southfield : Providence Cancer Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Minnesota

Duluth : Essentia Health Oncology Clinical Trials

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Duluth : Duluth Clinic Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Minneapolis : Childrens Hospital & Clinics of Minnesota

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Minneapolis : University of Minnesota

A clinical trial to evaluate treatments using GNKG168 for patients with Leukemia

Minneapolis : Novartis Investigative Site

A Phase 1/Phase 2 clinical study for patients using HSC835

Minneapolis : University of Minnesota

A Phase 2 clinical study for patients using Plerixafor

Minneapolis : University of Minnesota Cancer Center-Fairview Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Minneapolis : University of Minnesota

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Minneapolis : University of Minnesota - Masonic Cancer Center

Patients are needed to participate in a clinical research study evaluating CNDO-109-AANK Cells for the treatment of Acute Myeloid Leukemia

Minneapolis : Childrens Hospital & Clinics of Minnesota

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Rochester : Mayo Clinic - Rochester

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Rochester : Mayo Clinic, Rochester

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Rochester : Mayo Clinic

A Phase 2 clinical study for patients using Plerixafor

Rochester : Mayo Clinic

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Rochester : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Rochester : Mayo Clinic

A Phase 3 clinical study for patients with AML

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CDX-1127

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Rochester : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Rochester : Mayo Clinic

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

St. Louis Park : Metro MN CCOP/Park Nicollet Institute

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

St. Louis Park : Park Nicollet Institute Metro - MN CCOP

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Louis Park : Park Nicollet Institute - Louisiana Ave.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Louis Park : Metro Minnesota Community Clinical Oncology Program

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Woodbury : Minnesota Oncology Hematology, PA

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Mississippi

Hattiesburg : Hattiesburg Clinic

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Jackson : University of Mississippi Medical Center Peds Heme/Onc Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Southaven : US Oncology - University of Tennessee Cancer Institute - Southaven

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tupelo : North Mississippi Hematology and Oncology Assoc., Ltd.

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Missouri

Branson : Branson Oncology Clinic

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Columbia : US Oncology - Missouri Cancer Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Creve Coeur : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Jefferson City : Capitol Comprehensive Cancer Care Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kansas City : Updated

A clinical research study of cytarabine and vismodegib for the treatment of Myelodysplastic Syndromes, Myelogenous Leukemia, Acute

Kansas City : Research Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kansas City : Mercy Children's Kansas University Updated

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Kansas City : Saint Luke's Cancer Institute

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Kansas City : Children's Mercy Hospitals and Clinics

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Springfield : St John's Clinic for Cancer and Hematology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Springfield : St. John's Medical Research Institute

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Joseph : St. Joseph Oncology, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Louis : Washington University School Of Medicine-Siteman Cancer Ctr Washington U School of Med

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

St. Louis : Washington University School of Medicine

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

St. Louis : Washington University School of Medicine

A clinical trial seeking patients for a research study for the treatment of AML

St. Louis : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

St. Louis : 1315.1.1004 Boehringer Ingelheim Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

St. Louis : Hematology Oncology Consultants, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

St. Louis : Washington University School of Medicine

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

St. Louis : 1230.30.10005 Boehringer Ingelheim Investigational Site Updated

A Phase 1 clinical study for patients with Leukemia, Myeloid, Acute

St. Louis : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

St. Louis : Washington University School of Medicine

A Phase 1/Phase 2 clinical study for patients with Leukemia, Lymphoma or Multiple Myeloma

St. Louis : Washington University

A Phase 2 clinical study for patients using Plerixafor

St. Louis : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

St. Louis : Washington University School of Medicine

A Phase 3 clinical study for patients with AML

St. Louis : Washington University School of Medicine Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

St. Louis : Washington University

Patients are needed to participate in a clinical research study evaluating CNDO-109-AANK Cells for the treatment of Acute Myeloid Leukemia

St. Louis : Washington University Medical School

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

St. Louis : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

St. Louis : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

St. Louis :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

St. Louis : Washington University School of Medicine

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

St. Louis : St. Louis Hematology Oncology Specialists, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

St. Louis : St. Louis University Cancer Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Montana

Billings : Billings Clinic

A clinical research study for the treatment of Chronic Myeloid Leukemia

Missoula : Montana Cancer Institute Foundation

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Nebraska

Lincoln : Southeast Nebraska Hematology & Oncology Consultants, PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lincoln : Nebraska Hematology Oncology, PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Omaha : Omaha VAMC

A clinical research study for the treatment of Chronic Myeloid Leukemia

Omaha : University of Nebraska Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Omaha : The Nebraska Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Omaha : Nebraska Medical Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Omaha : Nebraska Methodist Hospital

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Omaha : Oncology Hematology West PC dba Nebraska Cancer Specialists

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Omaha : University of Nebraska Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Nevada

Carson City : Sierra Nevada Oncology Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Las Vegas : Southern Nevada Cancer Research Foundation

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Las Vegas : Comprehensive Cancer Centers of Nevada

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Las Vegas : Nevada Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Reno : VA Sierra Nevada Healthcare System

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Hampshire

Lebanon : Dartmouth - Hitchcock Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Portsmouth : Portsmouth Regional Hospital

A clinical research study for the treatment of Chronic Myeloid Leukemia

New Jersey

Brick : New Jersey Hematology Oncology Associates

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Cherry Hill : The Center for Cancer and Hematologic Disease

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cherry Hill : The Center for Cancer and Hematologic Disease

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Elizabeth : Ellioth Fishkin, MD

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Englewood : Drs. Forte, Schleider, Attas & Condemi, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hackensack : Hackensack University Medical Center Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Hackensack : Hackensack University Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Hackensack : John Theurer Cancer Center At Hackensack University Medical Center

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

Hackensack : Hackensack University Medical Center Hackensack Univ Med Ctr (32)

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Hackensack : Hackensack University Medical Center

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

Hackensack : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Hackensack : The Cancer Center at Hackensack University Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Hackensack : Hackensack University Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Hackensack : Site Reference ID/Investigator# 92500

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Hackensack : Hackensack University Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Hackensack : Hackensack University Medical Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Hackensack : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Hackensack : John Theurer Cancer Center Hackensack University Medical Center

A Phase 1/Phase 2 clinical study for patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Hackensack : Hackensack University Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Hackensack : Hackensack University Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Hackensack : John Theurer Cancer Center at Hackensack University Medical Center

Patients are needed to participate in a clinical research study evaluating HSV-Tk and T cell repletion strategies for the treatment of High Risk Acute Leukemia

Hackensack : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Hackensack : John Theurer Cancer Center at the Hackensack University Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Morristown : Hematology-Oncology Associates of Northern NJ, PA

A clinical research study for the treatment of Chronic Myeloid Leukemia

Morristown : Hematology Oncology of Northern New Jersey

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Morristown : Hematology /Oncology Associates of Northern New Jersey

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Morristown : Hematology Oncology Associates of Northern New Jersey

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

New Brunswick : Rutgers Cancer Institute of New Jersey (CINJ)

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

New Brunswick : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

New Brunswick : Saint Peter's University Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

New Brunswick : Site Reference ID/Investigator# 92513

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

New Brunswick : Robert Wood Johnson University Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New Brunswick : The Cancer Institute of New Jersey

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New Brunswick : Rutgers Cancer Institute of New Jersey Updated

A Phase 2 clinical study for patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

New Brunswick : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Somerville : Steeplechase Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sparta : Sparta Cancer Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Teterboro : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Vineland : Southern Oncology Hematology

A clinical research study for the treatment of Chronic Myeloid Leukemia

New Mexico

Albuquerque : University of New Mexico Cancer Center

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Albuquerque : UNM Cancer Center IP Only

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Albuquerque : University of New Mexico Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Farmington : San Juan Oncology Associates

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

New York

Albany : Samuel S Stratton VAMC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bay Shore : Hematology Oncology Associates of Western Suffolk

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bronx : Montefiore Medical Center / AECOM

A clinical research study for the treatment of Chronic Myeloid Leukemia

Bronx : Montefiore Medical Center

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

Bronx : Children's Hospital at Montefiore

A clinical trial seeking patients for a research study of Aromatherapy Scented Wand and Placebo wand

Bronx : Eastchester Center for Cancer Care

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bronx : Bronx River Medical Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bronx : Montefiore Medical Center

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Bronxville : Eduardo Saponara, MD

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Buffalo : Roswell Park Cancer Institute

A clinical research study of eltrombopag olamine and standard follow-up care

Buffalo : Roswell Park Cancer Institiute

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Buffalo : Jonah Cancer Care Center & ECMC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Buffalo : Research Site

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Buffalo : Roswell Park Cancer Institute

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

Buffalo : Roswell Park Cancer Institute

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Buffalo : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Buffalo : Roswell Park Cancer Institute

A Phase 3 clinical study for patients with AML

Buffalo : Roswell Park Cancer Institute

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Buffalo :

Patients are needed to participate in a clinical research study evaluating GDC-0199 (ABT-199) and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic

Buffalo : Roswell Park Cancer Institute

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Buffalo : Roswell Park Cancer Institute

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Buffalo : Teva Investigational Site 12547 Updated

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

Glens Falls : C.R. Wood Cancer Center at Glens Falls Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Hawthorne : New York Medical College

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Hawthorne : Westchester Hematology Oncology Group, PC

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Johnson City : Broome Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Johnson City : Broome Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lake Success : Monter Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Lake Success : Clinical Research Alliance

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Lake Success : North Shore-LIJ Health System Monter Cancer Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Manhasset : North Shore University Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Mineola : Winthrop University Hospital Oncology/ Hematology

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Mount Kisco : Westchester Hematology Oncology Associates

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

New Hyde Park : North Shore University Hospital

A clinical trial to evaluate treatments using GNKG168 for patients with Leukemia

New Hyde Park : Long Island Jewish Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New Hyde Park : Long Island Jewish Medical Center

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

New York : New York Presbyterian Hospital / Weill Cornell Medical College Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

New York : St. Lukes Roosevelt Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

New York : Advanced Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

New York : Updated

A clinical research study of cytarabine and vismodegib for the treatment of Myelodysplastic Syndromes, Myelogenous Leukemia, Acute

New York : Memorial Sloan Kettering Updated

A clinical research study of Cytarabine, Lintuzumab-Ac225, Lasix and Spironolactone for the treatment of Leukemia

New York : Columbia University Medical Center (Cumc)

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

New York : Memorial Sloan Kettering Cancer Center Oncology

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

New York : Children's Hospital New York-Presbyterian

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

New York : New York University Medical Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

New York : Weill Medical College of Cornell Updated

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

New York : GSK Investigational Site

A clinical trial seeking patients for a Cancer treatment research study

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

New York : Memorial Sloan Kettering

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

New York : Columbia Presbyterian

A clinical trial seeking patients for a research study for the treatment of Adult T-cell Leukemia-Lymphoma

New York : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

New York : Memorial Sloan Kettering Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

New York : Weill Cornell Medical College

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

New York : Columbia University Medical Center

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

New York : Site Reference ID/Investigator# 56810

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

New York : Site Reference ID/Investigator# 94716

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

New York : Site Reference ID/Investigator# 103835

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

New York : Weill Cornell Medical College

A clinical trial to evaluate treatments using CPX-351 for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

New York : Columbia University Medical Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

New York : Weill Cornell-New York Presbyterian Hospital

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

New York : Memorial Sloan Kettering Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

New York : New York Presbyterian Hospital - Weill Cornell Medical College

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New York : Memorial Sloan-Kettering Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New York : New York Presbyterian Hospital - Weill Cornell Medical College

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

New York : Memorial Sloan-Kettering Cancer Center Updated

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

New York : New York Presby Hospital, Weill Medical College at Cornell University

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

New York : Weill Cornell Medical College

A clinical trial to evaluate treatments using TEN-010 for patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

New York : Cornell

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

New York :

A Phase 1 clinical study for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

New York : Memorial Sloan Kettering Cancer Center

A Phase 1 clinical study for patients with Lymphoblastic Leukemia, Acute T-cell or Precursor T-Cell Lymphoblastic Lymphoma

New York : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

New York : Columbia University Medical Center

A Phase 3 clinical study for patients with AML

New York : Memorial Sloan-Kettering Cancer Center

A Phase 4 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

New York :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

New York : Columbia University Medical Center Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

New York : Weill Cornell Medical College

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

New York : Beth Israel Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study evaluating BPX-501 and AP1903 for the treatment of Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia or Lymphoma

New York : Icahn School of Medicine at Mount Sinai Hess Center for Science and Medicine

Patients are needed to participate in a clinical research study evaluating CDX-1127

New York :

Patients are needed to participate in a clinical research study evaluating GDC-0199 (ABT-199) and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic

New York : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study evaluating Lenalidomide for the treatment of Adult T Cell Leukemia/Lymphoma

New York : Weill Cornell Medical College

Patients are needed to participate in a clinical research study evaluating plerixafor and decitabine for the treatment of Acute Myeloid Leukemia

New York : Columbia University Medical Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

New York : Weill Cornell Medical Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

New York : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of EPZ-5676

New York : Weill Cornell Medical College

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

New York : Mount Sinai Medical Center

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

New York : Memorial Sloan-Kettering Cancer Center

Patients are needed to participate in a clinical research study of Palifermin, Lupron, without the addition of palifermin or Lupron and peripheral blood stem cell transplantation to evaluate Leukemia, Multiple Myeloma, Myelodysplastic Syndrome or Non-Hodgkin's Lymphoma

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

New York : Beth Israel Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

New York : Memorial Sloan Kettering Cancer Center

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

New York : Children's Hospital New York-Presbyterian

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

New York : New York University Medical Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Rochester : Rochester General Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Rochester : University of Rochester

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Rochester : University of Rochester Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Rochester : University of Rochester

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Rochester : University of Rochester

A Phase 3 clinical study for patients with AML

Rochester : University of Rochester

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Rochester : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Stony Brook : Stony Brook University Hospital

A clinical research study for the treatment of Chronic Myeloid Leukemia

Stony Brook : Stony Brook University Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Stony Brook : Stony Brook University Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Stony Brook : Stony Brook University Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Stony Brook : Stony Brook University Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Stony Brook : SUNY at Stony Brook SUNY at Stony Brook 2

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Stony Brook : Stony Brook University Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Syracuse : SUNY Upstate Medical University - Adult Program

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Syracuse : SUNY Upstate Medical University

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Syracuse : SUNY Upstate Medical University

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Valhalla : Westchester Medical Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Valhalla : Updated

Patients are needed to participate in a clinical research study evaluating RO5503781 and cytarabine for the treatment of Myelogenous Leukemia, Acute

North Carolina

Cary : Waverly Hematology Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Cary : US Oncology - Cancer Centers of North Carolina - Cary

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chapel Hill : University of North Carolina at Chapel Hill University of North Carolina 6

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Chapel Hill : UNC Healthcare

A clinical trial seeking patients for a research study for the treatment of Chronic Myeloid Leukemia

Chapel Hill : UNC Hospitals - The University of North Carolina at Chapel Hill

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Chapel Hill : UNC Cancer Hospital Infusion Pharmacy

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Chapel Hill : University of North Carolina

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Chapel Hill : University of North Carolina at Chapel Hill - Lineberger Comprehensive Cancer Center

Patients are needed to participate in a clinical research study of Lenalidomide to evaluate Acute Myeloid Leukemia

Charlotte : Levine Children's Hospital at Carolinas Medical Center

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Charlotte : Carolinas Medical Centre-Levine Cancer Institute

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Charlotte : Investigational Pharmacy

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Charlotte : Levine Children's Hospital at Carolinas Medical Center

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Durham : Duke University Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Durham : Duke University

A clinical research study of L-asparaginase encapsulated in RBC for the treatment of Acute Lymphoblastic Leukemia

Durham : Duke University Medical Center Updated

A clinical research study of NiCord® for the treatment of Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Durham : Duke University Medical Center

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Durham : Duke University Medical Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Durham : Duke University Medical Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Durham : 1230.30.10003 Boehringer Ingelheim Investigational Site Updated

A Phase 1 clinical study for patients with Leukemia, Myeloid, Acute

Durham : Duke University

A Phase 2 clinical study for patients using Plerixafor

Durham : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Durham : Duke University Medical Center Duke University Med Ctr

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

Durham : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Durham : Duke University Health System

Patients are needed to participate in a clinical research study of EPZ-5676

Durham : Duke University Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Durham : Duke University

Patients are needed to participate in a clinical research study of SG2000 to evaluate Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Gastonia : Gaston Hematology Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Greenville : East Carolina University

A clinical research study for the treatment of Chronic Myeloid Leukemia

Raleigh : Rex Cancer Center

A clinical trial seeking patients for a research study for the treatment of Chronic Myeloid Leukemia

Raleigh : Rex Cancer Center - Wakefield

A clinical trial seeking patients for a research study for the treatment of Chronic Myeloid Leukemia

Raleigh : US Oncology - Cancer Centers of North Carolina - Macon

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Raleigh : US Oncology - Cancer Centers of North Carolina - Falls

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Winston-Salem : Wake Forest Baptist Health

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Winston-Salem : Wake Forest University Baptist Health

A Phase 3 clinical study for patients with AML

North Dakota

Bismarck : Legacy Pharma Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bismarck : Mid Dakota Clinic/Odyssey Research

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fargo : Roger Maris Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Ohio

Akron : Summa Health System

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Akron : Akron General Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Akron : Summa Health System - Cancer Research Office

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Akron : Summa Health System Hospitals

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Canton : Gabrail Cancer Center Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Canton : Gabrail Cancer Center Research

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Canton : Gabrail Cancer Center Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Canton : Gabrail Cancer Center Research

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Canton : Gabrail Cancer Center

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Canton : Nashat Y. Gabrail, MD, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Canton : Gabrail Cancer Center Research

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Cincinnati : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Cincinnati : Cincinnati Children's Hospital Medical Center

A clinical trial seeking patients for a research study for the treatment of Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia or Acute Leukemias

Cincinnati : Oncology Hematology Care, Inc.

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Cincinnati : Cincinnati Children's Hospital Updated

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Cincinnati : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Cincinnati : University of Cincinnati Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center Cincinnati Children's Hosp

A Phase 1 clinical study for patients with Chronic Myeloid Leukemia or Acute Lymphoblastic Leukemia

Cincinnati : Oncology Hematology Associates

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia

Cincinnati : Oncology Hematology Care, Incorporated

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Cincinnati : University of Cincinnati Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Cincinnati : Cincinnati Children's Hospital Medical Center

Patients are needed to participate in a clinical research study evaluating CPX-351 in Children With Relapsed Acute Myeloid Leukemia (AML)

Cincinnati : Oncology Hematology Care

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Cincinnati : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Cincinnati : Teva Investigational Site 12546 Updated

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

Cincinnati : University of Cincinnati

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Cincinnati : Cincinnati Children's Hospital Medical Center

Patients are needed to participate in a clinical research study of SGN-CD19A to evaluate Burkitt Lymphoma or Precursor B-cell Lymphoblastic Leukemia-Lymphoma

Cleveland : Rainbow Babies

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Cleveland : University Hospitals Case Medical Center

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Cleveland : Cleveland Clinic Updated

A clinical research study of Ruxolitinib for the treatment of Myelomonocytic Leukemia

Cleveland : Site Reference ID/Investigator# 92495

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Cleveland : Site Reference ID/Investigator# 108136

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Cleveland : Case Western

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Cleveland : Cleveland Clinic Foundation

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Cleveland : University Hospitals Case Medical Center - Case Western Reserve University

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Cleveland :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Cleveland : University Hospitals Case Medical Center Updated

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

Cleveland : Cleveland Clinic

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Cleveland : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Cleveland : Cleveland Clinic

A Phase 2 clinical study for patients using Plerixafor

Cleveland : Rainbow Babies & Children's Hospital Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Cleveland : University Hospitals of Cleveland

Patients are needed to participate in a clinical research study evaluating BPX-501 and AP1903 for the treatment of Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia or Lymphoma

Cleveland : Cleveland Clinic

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Cleveland : Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Cleveland : Cleveland Clinic Foundation

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Cleveland : Cleveland Clinic, The

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Cleveland : Rainbow Babies

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Columbus : Ohio State University Comprehensive Cancer Center Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Columbus : For additional information regarding sites for this trial call (919) 465-4648

A clinical research study of 20 mg/kg TRU-016 + Rituximab, 10 mg/kg TRU-016 + Rituximab and TRU-016 20 mg/kg + Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

Columbus : The Ohio State University Comprehensive Cancer Center

A clinical research study of IMMU-114 to evaluate Lymphoma

Columbus : Ohio State University

A clinical research study of L-asparaginase encapsulated in RBC for the treatment of Acute Lymphoblastic Leukemia

Columbus : Nationwide Childrens Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Columbus : Ohio State University Medical Center

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukemia

Columbus : 1315.1.1001 Boehringer Ingelheim Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

Columbus : Mid Ohio Oncology / Hematology, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

A clinical trial to evaluate treatments using MOR00208, lenalidomide and Correlative Studies for Patients With Relapsed or Refractory CLL, SLL or PLL or Older Patients With Untreated CLL, SLL or PLL

Columbus : OSU

A clinical trial to evaluate treatments using TG02 citrate for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Columbus :

A Phase 1 clinical study for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Columbus : Ohio State University

A Phase 2 clinical study for patients using Plerixafor

Columbus :

ACP-196 in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

Columbus : Site Reference ID/Investigator# 127263

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Chronic Lymphocytic Leukemia (CLL)

Columbus : The Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating CDX-1127

Columbus : Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center

Patients are needed to participate in a clinical research study evaluating decitabine, selinexor, pharmacological study and laboratory biomarker analysis for the treatment of Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia or Untreated Adult Acute Myeloid Leukemia

Columbus :

Patients are needed to participate in a clinical research study evaluating GDC-0199 (ABT-199) and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic

Columbus : Ohio State University Comprehensive Cancer Center

Patients are needed to participate in a clinical research study evaluating milatuzumab for Graft Versus Host Disease

Columbus :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Columbus : Ohio State University Comprehensive Cancer Center - The James

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Columbus : Nationwide Childrens Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Elyria : Hematology Oncology Center, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fairfield : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Fairfield : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Middletown : Signal Point Clinical Research Center, LLC

A clinical research study for the treatment of Chronic Myeloid Leukemia

Middletown : Signal Point Clinical Research Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Newark : Medical Center of Newark

A clinical research study for the treatment of Chronic Myeloid Leukemia

Sylvania : Promedica Hematology & Oncology Assoicates

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Phase Chronic Myeloid Leukemia

Oklahoma

Oklahoma City : Peggy and Charles Stephenson Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Oklahoma City : OU Medical Center Presbyterian Tower

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Oklahoma City : Oklahoma University

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Tulsa : Cancer Care Associates

A clinical research study for the treatment of Chronic Myeloid Leukemia

Oregon

Eugene : US Oncology - Willamette Valley Cancer Institute - Eugene

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Eugene :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Portland : Oregon Health & Science University

A clinical research study for the treatment of Chronic Myeloid Leukemia

Portland : Oregon Health Sciences University

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Portland : Oregon Health and Science University

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Portland : Oregon Health and Sciences University

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Broadway

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Hoyt

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Portland : US Oncology - Northwest Cancer Specialists, PC - Portland - Barnes

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Portland : Oregon Health & Sciences University

A clinical trial to evaluate treatments using GNKG168 for patients with Leukemia

Portland : Oregon Health & Science University SC-6

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Portland : Oregon Health & Science University

A Phase 2 clinical study for patients with Acute Myelogenous Leukemia or Acute Lymphoblastic Leukemia

Portland : Oregon Health and Science University Knight Cancer Institute

A Phase 3 clinical study for patients with AML

Portland : Oregon Health and Science University Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Portland : Oregon Health & Science University

Patients are needed to participate in a clinical research study evaluating BPX-501 and AP1903 for the treatment of Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia or Lymphoma

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study evaluating CDX-1127

Portland : Oregon Health & Science University Oregon Health & Science U (56)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Portland : OHSU Knight Cancer Institute

Patients are needed to participate in a clinical research study of Dasatinib to evaluate Chronic Lymphocytic Leukemia (CLL)

Portland :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Portland : Oregon Health and Science University

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Salem : Salem Health

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Salem : Hematology/Oncology Salem LLP

A clinical research study for the treatment of Chronic Myeloid Leukemia

Salem : Salem Health

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Springfield : US Oncology - Willamette Valley Cancer Institute - Springfield

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Springfield : Williamette Valley Cancer Center and Research Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Springfield : Willamette Valley Cancer Center and Research Institute

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Tualatin : US Oncology - Northwest Cancer Specialists, PC - Tualatin

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Pennsylvania

Abington : Abington Memorial Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Bethlehem : Oncology Hematology of Lehigh Valley

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Danville : Geisinger Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Drexel Hill : Consultants in Medical Oncology and Hematology, PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Gettysburg : Gettysburg Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Gettysburg : Gettysburg Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Gettysburg : Gettysburg Cancer Center

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Hershey : Penn State Hershey Cancer Institute

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Hershey : Penn State Milton S. Hershey Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Hershey : Penn State Milton S. Hershey Medical Center,

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Hershey : Penn State Milton S Hershey Medical Center

A Phase 3 clinical study for patients with AML

Hershey : Penn State Milton S. Hershey Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Hershey : Penn State Milton S. Hershey Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Kingston : Medical Oncology Associates of Wyoming Valley, PC

A clinical research study for the treatment of Chronic Myeloid Leukemia

Kingston : US Oncology - Medical Oncology Associates (Nahar)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lancaster : Lancaster General Health

A clinical research study for the treatment of Chronic Myeloid Leukemia

Lancaster : Lancaster Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Norristown : Luitpold Pharmaceuticals, Inc.

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia

Philadelphia : Temple BMT Program at Jeanes Hospital

A clinical research study of Decitabine, Carboplatin and Arsenic trioxide for the treatment of Acute Myeloid Leukemia, Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia

Philadelphia : Abramson Cancer Center of the University of Pennsylvania

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Philadelphia : University of Pennsylvania - Perelman Center for Advanced Medicine

A clinical trial seeking patients for a research study for the treatment of Acute Leukemia (AML), Myelodysplastic Syndrome (MDS) or Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)

Philadelphia : Hospital of the University of Pennsylvania

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Philadelphia : Drexel University College of Medicine

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Philadelphia : Thomas Jefferson University Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Philadelphia : Thomas Jefferson University

A clinical trial to evaluate treatments using Bortezomib with mitoxantrone, etoposide and cytarabine for patients with Relapsed Acute Leukemia or Refractory Acute Leukemia

Philadelphia : Children's Hospital of Philadelphia Updated

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Philadelphia : University of Pennsylvania, Abramson Cancer Center

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

Philadelphia : University of Pennsylvania Health System

A Phase 3 clinical study for patients with AML

Philadelphia : Children's Hospital of Philadelphia Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Philadelphia : University of Pennsylvania-Abramson CCC-Dept.of Hem Onc

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Philadelphia : Thomas Jefferson University

Patients are needed to participate in a clinical research study evaluating Bendamustine, Pentostatin and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or B-Cell Non-Hodgkin's Lymphoma

Philadelphia : Temple University Bone Marrow Transplant Program

Patients are needed to participate in a clinical research study evaluating Decitabine, Carboplatin and Arsenic Trioxide for the treatment of Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Philadelphia : Fox Chase Cancer Center Dept of Medical Oncology

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Philadelphia : Updated

Patients are needed to participate in a clinical research study evaluating RO5503781 and cytarabine for the treatment of Myelogenous Leukemia, Acute

Philadelphia : Abramson Cancer Center of the University of Pennsylvania

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Pittsburgh : Veterans Research Foundation of Pittsburgh

A clinical research study for the treatment of Chronic Myeloid Leukemia

Pittsburgh : UPMC Cancer Center - Hillman Cancer Center

A clinical trial to evaluate treatments using Neukoplast™ (NK-92) for patients with Acute Myeloid Leukemia

Pittsburgh : Children's Hospital of Pittsburgh of UPMC Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Pottstown : Pottstown Memorial Regional Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Reading : Berks Hematology Oncology Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Wilkes-Barre : Geisinger Health System

A clinical research study for the treatment of Chronic Myeloid Leukemia

Willow Grove : Abington Hematology Oncology Associates

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

York : Cancer Care Association Of York

A clinical research study for the treatment of Chronic Myeloid Leukemia

Rhode Island

Cranston : Hematology and Oncology Associates of RI

A clinical research study for the treatment of Chronic Myeloid Leukemia

Cranston : Hematology & Oncology Associates of Rhode Island

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Cranston : Sambandam and Joseph Associates, Inc

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Providence : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Providence : Rhode Island Hospital Rhode Island Hosp. (2)

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

South Carolina

Charleston : Charleston Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Charleston : Medical University of South Carolina, Hollings Cancer Center

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Charleston : Charleston Hematology Oncology Associates, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Charleston : Hollings Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Charleston : MUSC Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Charleston : MUSC Investigational Drug Services

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Charleston : Medical Center for the University of South Carolina

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study evaluating CNDO-109-AANK Cells for the treatment of Acute Myeloid Leukemia

Charleston : Charleston Hematology Oncology, PA

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Charleston : Updated

Patients are needed to participate in a clinical research study of RO6839921 to evaluate Neoplasms, Myelogenous Leukemia, Acute

Charleston : Medical University of South Carolina

Patients are needed to participate in a clinical research study of SG2000 to evaluate Acute Myeloid Leukemia or Chronic Lymphocytic Leukemia

Columbia : South Carolina Oncololgy Associates, PA

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Columbia : South Carolina Oncology Associates

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Easley : US Oncology - Cancer Centers of the Carolinas - Easley

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : US Oncology - Cancer Centers of the Carlinas - Eastside

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : US Oncology - Cancer Centers of the Carolinas - West Faris

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : US Oncology - Cancer Centers of the Carolinas - Butternut

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Greenville : Saint Francis Hospital

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Greenville : Greenville Health System Cancer Institute

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Greenville : Greenville Hospital System

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Greenville : Bon Secours Saint Francis Health System

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Greenville : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Greenville : Saint Francis Hospital

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Rock Hill : Carolina Blood and Cancer Care Associates, P.A.

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Seneca : US Oncology - Cancer Centers of the Carolinas - Seneca

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spartanburg : Spartanburg Regional Medical Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Spartanburg : Spartanburg Regional Health Services District, Inc.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spartanburg : US Oncology - Cancer Centers of the Carolinas - Spartanburg

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

South Dakota

Sioux Falls : Avera Research Institute

A clinical research study for the treatment of Chronic Myeloid Leukemia

Sioux Falls : Sanford Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Sioux Falls : Avera Cancer Institute

A Phase 3 clinical study for patients with AML

Sioux Falls : Sanford Research Sanford Health

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Watertown : Prairie Lakes Health Systen, Inc

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Watertown : Prairie Lakes Healthcare System, Inc

A clinical research study for the treatment of Chronic Myeloid Leukemia

Watertown : Prairie Lakes Healthcare System Inc.

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Watertown : Prairie Lakes Health Care System, Inc.

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Watertown : Prairie Lakes Healthcare System Inc.

Patients are needed to participate in a clinical research study of Idelalisib and Rituximab to evaluate B-cell Chronic Lymphocytic Leukemia (CLL) With 17p Deletion

Tennessee

Bartlett : US Oncology - University of Tennessee Cancer Institute - Bartlett

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Chattanooga : Tennessee Oncology

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Chattanooga : Chattanooga Oncology Hematology Associates

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia

Chattanooga : Associates in Oncology and Hematology

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Chattanooga : Associates in Oncology and Hematology

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Collierville : Family Cancer Center, PLLC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Collierville : The Family Cancer Center

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Germantown : US Oncology - University of Tennessee Cancer Institute - Germantown

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Germantown : Jones Clinic PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Germantown : C. Michael Jones, MD, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Knoxville : University of Tennessee Medical Center Cancer Intitute

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Knoxville : Tennessee Cancer Specialists

A clinical research study for the treatment of Chronic Myeloid Leukemia

Memphis : St. Jude

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Memphis : St. Jude Children's Research Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukemia

Memphis : St. Jude Children's Research Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukemia

Memphis : St. Jude Children's Research Hospital

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Memphis : TG Therapeutics Investigational Trial Site

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Memphis : US Oncology - University of Tennessee Cancer Institute - Memphis

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Memphis : St. Jude Children's Research Hospital

A Phase 1 clinical study for patients with Hodgkin Lymphoma, Non-Hodgkin Lymphoma or Acute Leukemia

Memphis : St. Jude Children's Research Hospital

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Memphis : Saint Jude Children's Research Hospital Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Memphis : St. Jude

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Nashville : Vanderbilt-Ingram Cancer Center / Vanderbilt University Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Nashville : Tennessee Oncology/Sarah Cannon Research Institute Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

Nashville : Tennessee Oncology Sarah Cannon Research Inst.

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Nashville : Vanderbilt Univeristy Oncology

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Nashville : Vanderbilt Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Nashville : Vanderbilt University

A clinical research study of Phase I- Cytarabine & Eltrombopag, Phase II- Sequence A and Phase II- Sequence B for the treatment of Acute Myeloid Leukemia

Nashville :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

Nashville : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nashville : Tennessee Oncology

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Nashville : Vanderbilt U Medical Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Nashville : SCRI

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Nashville : Sarah Cannon Research Institute (SCRI) Drug Development Unit

A clinical trial to evaluate treatments using CC-115 for patients

Nashville : Sarah Cannon Research Institute

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Nashville : Tennessee Oncology, PLLC

A clinical trial to evaluate treatments using IPI-145, Rituximab and Bendamustine for patients with Lymphoma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma or T-cell Lymphoma

Nashville : SCRI

A clinical trial to evaluate treatments using TG02 citrate for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nashville : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Nashville : Tennessee Oncology PLLC

A Phase 2 clinical study for patients with Chronic Lymphocytic Leukemia

Nashville : Sarah Cannon Res Inst

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Nashville : Vanderbilt-Ingram Cancer Center

A Phase 3 clinical study for patients with AML

Nashville :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Nashville : Vanderbilt University Medical Center

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating CDX-1127

Nashville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Nashville :

Patients are needed to participate in a clinical research study evaluating GDC-0199 (ABT-199) and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic

Nashville : Tennessee Oncology, PLLC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Nashville : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Nashville : Tennessee Oncology/Sarah Cannon Research Insitute

Patients are needed to participate in a clinical research study evaluating PRT062070 for the treatment of Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or B-cell Non Hodgkin Lymphoma (NHL)

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Nashville : Tennessee Oncology, PLLC

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Nashville : Sarah Cannon Research Institute

Patients are needed to participate in a clinical research study of EPZ-5676

Nashville :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Nashville : Vanderbilt University Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Nashville : Vanderbilt Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Texas

Abilene : US Oncology - Texas Cancer Center - Abilene (South)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Amarillo : Texas Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Amarillo : US Oncology - Texas Oncology, PA - Amarillo

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Arlington : Texas Oncology - Arlington South

A clinical research study for the treatment of Chronic Myeloid Leukemia

Arlington : US Oncology - Texas Oncology - Arlington South

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Arlington : Arlington Cancer Center

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Austin : Texas Oncology-Austin North

A clinical research study for the treatment of Chronic Myeloid Leukemia

Austin : Texas Oncology-Austin Midtown

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Austin : Texas Oncology-Austin Midtown

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Beaumont : Julie & Ben Rogers Cancer Institute

A clinical research study for the treatment of Chronic Myeloid Leukemia

Bedford : US Oncology - Texas Oncology, PA - Bedford

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Bryan : St. Joseph Regional Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

College Station : Scott & White Clinic

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Corpus Christi : South Texas Institute of Cancer

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Corpus Christi : Coastal Bend Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Dallas : Texas Oncology-Dallas Presbyterian Hospital

A clinical research study for the treatment of Chronic Myeloid Leukemia

Dallas : Texas Oncology-Methodist Charlton Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Dallas : Texas Oncology-Medical City Dallas

A clinical research study for the treatment of Chronic Myeloid Leukemia

Dallas : Ut Southwestern Medical Center

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Dallas : Baylor Charles A. Sammons Cancer Center

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

Dallas : Baylor Health Care System/Sammons Cancer Center Oncology

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Dallas : US Oncology - Texas Oncology, PA - Dallas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Dallas : Mary Crowley Cancer Research Centers

A clinical trial to evaluate treatments using CC-115 for patients

Dallas : Texas Oncology-Baylor Charles A. Sammons Cancer Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Dallas : Texas Oncology

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Dallas : Baylor University Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Dallas : University of Texas Southwestern Medical Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Dallas : Parkland Memorial Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Dallas : UT Southweastern University Hospital- St. Paul

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Dallas : UT Southwestern University Hospital- Zale Lipshy

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Dallas : UT Southwestern Medical Center: Simmons Pharmacy

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Dallas : Baylor Charles A. Sammons Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Dallas : UTSW UT Southwestern

A Phase 3 clinical study for patients with AML

Dallas :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Dallas : UT Southwestern Medical Center

Patients are needed to participate in a clinical research study evaluating BPX-501 and AP1903 for the treatment of Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia or Lymphoma

Dallas : Mary Crowley Cancer Research Centers - Medical City

Patients are needed to participate in a clinical research study evaluating CDX-1127

Dallas : Texas Oncology-Medical City Dallas

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Dallas : UT Southwestern Medical Center

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Dallas : Baylor University Medical Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Dallas : University of Texas at Southwestern

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

El Paso : US Oncology - El Paso Cancer Treatment Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

El Paso : US Oncology - El Paso Cancer Treatment Center - West

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Sam Houston : San Antonio Military Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Worth : Cook's Children's Medical Center

A clinical trial seeking patients for a research study for the treatment of Acute Myeloid Leukemia

Fort Worth : US Oncology - Texas Oncology, PA - Fort Worth

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Worth : US Oncology - Southwest Fort Worth Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fort Worth : The Center for Cancer and Blood Disorders

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Fort Worth : Center for Cancer and Blood Disorders

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Fort Worth : JPS Center for Cancer Care

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Fort Worth : Cook Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Galveston : University of Texas at Galveston

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Grapevine : US Oncology - Texas Oncology - Grapevine

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Houston : Michael DeBakey VA Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Houston : MD Anderson Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study for the treatment of Leukemia or Acute Lymphoblastic Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study for the treatment of Myelodysplastic Syndrome or Leukemia

Houston : For additional information regarding sites for this trial call (919) 465-4648

A clinical research study of 20 mg/kg TRU-016 + Rituximab, 10 mg/kg TRU-016 + Rituximab and TRU-016 20 mg/kg + Obinutuzumab for the treatment of Chronic Lymphocytic Leukemia

Houston : Site Reference ID/Investigator# 127860

A clinical research study of ABT-199, Decitabine and Azacitidine for the treatment of Acute Myelogenous Leukemia, Myelogenous Leukemia or Treatment Naive AML

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Cladribine and Rituximab for the treatment of Leukemia

Houston : Updated

A clinical research study of cytarabine and vismodegib for the treatment of Myelodysplastic Syndromes, Myelogenous Leukemia, Acute

Houston : University of Texas MD Anderson Cancer Center Updated

A clinical research study of Cytarabine, Lintuzumab-Ac225, Lasix and Spironolactone for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Dasatinib and Decitabine for the treatment of Leukemia

Houston : The University Of Texas Md Anderson Cancer Center

A clinical research study of Dasatinib for the treatment of Chronic Phase Chronic Myeloid Leukemia

Houston : MD Anderson Cancer Center

A clinical research study of DFP-10917 for the treatment of Acute Myeloid Leukemia or Acute Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Eltrombopag and Decitabine for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Lenalidomide for the treatment of Leukemia, Acute Myeloid Leukemia (AML)

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Lenalidomide, Influenza Vaccine and Pneumovax Vaccine for the treatment of Hematologic Disorder

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of MEK 162 for the treatment of Leukemia (AML)

Houston : M.D. Anderson Cancer Center

A clinical research study of PM01183 1 mg Powder for concentrate for solution for infusion and PM01183 4 mg Powder for concentrate for solution for infusion for the treatment of Acute Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Ponatinib for the treatment of Leukemia (CML)

Houston : University of Texas MD Anderson Cancer Center

A clinical research study of Vosaroxin and Decitabine for the treatment of Leukemia

Houston : GSK Investigational Site

A clinical trial seeking patients for a Cancer treatment research study

Houston : University of Texas M.D. Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Acute Lymphoblastic Leukemia

Houston : The University of Texas M.D. Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Lymphoma or Leukemia

Houston : The University of Texas MD Anderson Cancer Center

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Houston : The University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments for patients with Acute Myeloid Leukemia

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments using 100mg Crenolanib besylate, given three times daily for patients with Acute Myeloid Leukemia With FLT3 Activating Mutations That Has Relapsed or Been Refractory After One or More Prior Therapies

Houston : Site Reference ID/Investigator# 48326

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Houston : Site Reference ID/Investigator# 92521

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Brentuximab Vedotin and 5-Azacytidine for patients with Leukemia, Acute Myeloid Leukemia (AML)

Houston : The University of Texas, MD Anderson Cancer Center

A clinical trial to evaluate treatments using CC-115 for patients

Houston : The University Of Texas Md Anderson Cancer Center

A clinical trial to evaluate treatments using Dasatinib for patients with Chronic Phase Chronic Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Eltrombopag for patients with Leukemia

Houston : University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using Ibrutinib and Rituximab for patients with Leukemia

Houston : MD Anderson Cancer Center

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

Houston : The University of Texas MD Anderson Cancer Center

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Houston :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Houston : M. D. Anderson Cancer Center at University of Texas

A clinical trial to evaluate treatments using Lenalidomide and Rituximab for patients

Houston : UT MD Anderson Cancer Center

A clinical trial to evaluate treatments using Omacetaxine and Cytarabine for patients with Leukemia

Houston : MD Anderson Cancer Center Updated

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

Houston : University of Texas MD Anderson Cancer Center Updated

A clinical trial to evaluate treatments using Quizartinib, Cytarabine and AZA for patients with Leukemia

Houston : MDACC

A clinical trial to evaluate treatments using TG02 citrate for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Houston : The University of Texas, M.D. Anderson Cancer Center

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Houston : MD Anderson Cancer Center

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Houston :

A Phase 1 clinical study for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Houston : University of Texas MD Anderson Cancer Center

A Phase 1 clinical study for patients with Leukemia

Houston : 1230.30.10001 Boehringer Ingelheim Investigational Site Updated

A Phase 1 clinical study for patients with Leukemia, Myeloid, Acute

Houston : The University Of Texas Md Anderson Cancer Center

A Phase 1 clinical study for patients with Lymphoblastic Leukemia, Acute T-cell or Precursor T-Cell Lymphoblastic Lymphoma

Houston : MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Houston : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 1/Phase 2 clinical study for patients with Leukemia, Myeloma or Myeloproliferative Diseases

Houston : U.T. MD Anderson Cancer Center Houston

A Phase 1/Phase 2 clinical study for patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center Updated

A Phase 2 clinical study for patients with Advanced Cancers or Leukemia

Houston : Michael E Debakey Va Medical Center

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Leukemia

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Leukemia or Lymphoma

Houston : University of Texas MD Anderson Cancer Center Updated

A Phase 2 clinical study for patients with Leukemia or Lymphoma

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Leukemia, Myelodysplastic Syndrome (MDS)

Houston : University of Texas MD Anderson Cancer Center

A Phase 2 clinical study for patients with Leukemia, Myelogenous, Chronic

Houston : Research Site

A Phase 2 clinical study for patients with Relapsed/Refractory Philadelphia Positive B-precursor Acute Lymphoblastic Leukemia

Houston : MD Anderson Center, The University of Texas

A Phase 3 clinical study for patients with AML

Houston : University of Texas MD Anderson Cancer Center

A Phase 3 clinical study for patients with Disorder Related to Bone Marrow Transplantation, Leukemia or Transplantation Infection

Houston :

ACP-196 in Combination With ACP-319, for Treatment of Chronic Lymphocytic Leukemia

Houston :

Patients are needed to participate in a clinical research study evaluating AG-120 for the treatment of Relapsed/Primary Refractory Acute Myeloid Leukemia (AML) or Recurrent or Refractory Myelodysplastic Syndrome

Houston : Baylor College of Medicine Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Houston : MD Anderson Cancer Ctr

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating BKM120 for the treatment of Leukemia

Houston : The University of Texas, MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Decitabine, Carboplatin and Arsenic Trioxide for the treatment of Treatment of Relapsed, Refractory, and Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Houston : M D Anderson New

Patients are needed to participate in a clinical research study evaluating DS-3032b for the treatment of Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Eltrombopag and Hypomethylating Agent (HMA) for the treatment of Leukemia

Houston :

Patients are needed to participate in a clinical research study evaluating GDC-0199 (ABT-199) and Obinutuzumab for the treatment of Lymphocytic Leukemia, Chronic

Houston : Oncology Consultants Oncology Group

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Houston : University of Texas M.D. Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating PRI-724 for the treatment of Acute Myeloid Leukemia or Chronic Myeloid Leukemia

Houston : Updated

Patients are needed to participate in a clinical research study evaluating RO5503781 and cytarabine for the treatment of Myelogenous Leukemia, Acute

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Ruxolitinib for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating SGI-110, Idarubicin and Cladribine for the treatment of Leukemia

Houston : The University of Texas, MD Anderson Cancer Center

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Houston : UT MD Anderson Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia or Chronic Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study for the treatment of Leukemia, Lymphoblastic Lymphoma or Leukemia, Lymphoblastic, Acute

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of ATRA, ATO, GO (Gemtuzumab ozogamicin) and Methylprednisolone to evaluate Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Azacitidine to evaluate Leukemia, AML or MDS

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of BL-8040 +Ara-C to evaluate Acute Myeloid Leukemia

Houston : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of CB-839 to evaluate Acute Myeloid Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)

Houston : UT MD Anderson Cancer

Patients are needed to participate in a clinical research study of EPZ-5676

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Liposomal Annamycin to evaluate Acute Lymphocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ofatumumab to evaluate Chronic Lymphocytic Leukemia

Houston : Teva Investigational Site 12544 Updated

Patients are needed to participate in a clinical research study of Omacetaxine mepesuccinate to evaluate Chronic Myeloid Leukemia

Houston : The University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of oral rigosertib and Azacitidine to evaluate Myelodysplastic Syndrome, Acute Myeloid Leukemia or Chronic Myelomonocytic Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Rasburicase and Allopurinol to evaluate Leukemia or Lymphoma

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ruxolitinib and TKI to evaluate Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Ruxolitinib to evaluate Leukemia

Houston : MD Anderson Cancer Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Houston : MD Anderson Cancer Center / University of Texas

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Houston : University of Texas MD Anderson Cancer Center

Patients are needed to participate in a clinical research study to evaluate Leukemia

Kerrville : US Oncology - San Antonio Tumor & Blood Clinic - Kerrville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lewisville : Texas Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Longview : US Oncology - Longview Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lubbock : Joe Arrington Cancer Research and Treatment Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Lubbock : Joe Arrington Cancer Research and Treatment Center

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

McAllen : Texas Oncology-McAllen South Second

A clinical research study for the treatment of Chronic Myeloid Leukemia

McAllen : US Oncology - Texas Oncology - McAllen

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Mesquite : Texas Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Mesquite : US Oncology - Texas Oncology - Mesquite

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Midland : Texas Oncology-Midland Allison Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Midland : US Oncology - Allison Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Odessa : Texas Oncology-Odessa West Texas Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Paris : Texas Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Paris : US Oncology - Texas Oncology - Paris

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Plano : North Texas Regional Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Round Rock : Scott & White Healthcare Deparment of Research

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

San Antonio : Texas Transplant Institute/Sarah Cannon Research Institute Updated

A clinical research study for the treatment of Acute Myeloid Leukemia (AML)

San Antonio : Cancer Care Centers of South Texas

A clinical research study for the treatment of Chronic Myeloid Leukemia

San Antonio : Texas Transplant Physicians Group Oncology 2

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

San Antonio :

A clinical trial seeking patients for a research study for the treatment of Acute Myelogenous Leukemia

San Antonio : US Oncology - San Antonio Tumor & Blood Clinic - M. Oak

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

San Antonio : US Oncology - Cancer Care Centers of South Texas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

San Antonio : Texas Transplant Center at Methodist Healthcare System

A clinical trial to evaluate treatments using Infusion of one MPC expanded cord unit and one unexpanded cord unit and Infusion of two unexpanded cord blood units. for patients with Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma or Hodgkin's Disease

San Antonio : Methodist Healthcare System of San Antonio dba Methodist Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

San Antonio : Methodist Hospital Investigational Pharmacy

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

San Antonio : Cancer Therapy Reasearch Center at UTHSCA

Patients are needed to participate in a clinical research study evaluating Cordycepin plus Pentostatin for the treatment of Refractory TdT-Positive Leukemia

San Antonio : Cancer Care Network of South Texas

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

San Antonio : Updated

Patients are needed to participate in a clinical research study evaluating RO5503781 and cytarabine for the treatment of Myelogenous Leukemia, Acute

San Antonio : Methodist Healthcare System

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Sherman : US Oncology - Texas Oncology - Sherman

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : ETMC dba Blood and Cancer Center - East Texas

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : ETMC dba Tyler Hematology Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : US Oncology - Texas Oncology - Tyler

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tyler : Texas Oncology

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Waco : Texas Oncology

A clinical research study for the treatment of Chronic Myeloid Leukemia

Waco : US Oncology - Texas Oncology Cancer Care and Research Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Weslaco : US Oncology - Texas Oncology - Weslaco

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Wichita Falls : US Oncology - Texoma Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Utah

Logan : Cache Valley Cancer Treatment & Research Clinic, Inc.

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Ogden : Northern Utah Associates

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Salt Lake City : Primary Children's

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Salt Lake City : Utah Cancer Specialists

A clinical trial seeking patients for a research study for the treatment of Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

Salt Lake City : Research Site

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Salt Lake City : University of Utah Updated

A clinical trial to evaluate treatments using CTL019 T-cells for patients with B-cell Acute Lymphoblastic Leukemia, Relapsed B-cell Acute Lymphoblastic Leukemia or Refractory B-cell Acute Lymphoblastic Leukemia

Salt Lake City : Utah Cancer Specialists

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Salt Lake City : LDS Hospital

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Salt Lake City : LDS Hospital Updated

A Phase 2 clinical study for patients with Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL)

Salt Lake City : University of Utah, Huntsman Cancer Institute

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Salt Lake City : Utah Cancer Specialists

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Salt Lake City : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Salt Lake City : University of Utah Huntsman Cancer Institute - Div. of Hematology & Hematologic Malignncies

Patients are needed to participate in a clinical research study evaluating PGX-ODSH-2013-AML-1 for the treatment of Acute Myeloid Leukemia

Salt Lake City : University of Utah

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Salt Lake City : Primary Children's

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Virginia

Abingdon : Cancer Outreach Associates, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Arlington : US Oncology - Arlington Fairfax Hematology Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Charlottesville : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Christiansburg : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Christiansburg

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fairfax : US Oncology - Fairfax Northern VA Hem-Onc PC

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Fairfax : Virginia Cancer Specialists

Patients are needed to participate in a clinical research study evaluating ASP2215 for the treatment of Acute Myeloid Leukemia

Fairfax : Virginia Cancer Specialists, PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Fredericksburg : Hematology Oncology Associates of Fredricksburg

A clinical research study for the treatment of Chronic Myeloid Leukemia

Gainesville : US Oncology - Fairfax - Northern Virginia Hematology-Oncology, PC - Gainesville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Leesburg : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Leesburg

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Low Moor : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Low Moor

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Newport News : Peninsula Cancer Institute

A clinical research study for the treatment of Chronic Myeloid Leukemia

Norfolk : Virginia Oncology Associates

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

Richlands : Virginia Oncology Care, PC

Patients are needed to participate in a clinical research study of Nipent, Cytoxan, Rituxan to evaluate Chronic Lymphocytic Leukemia

Richmond : Virginia Commonwealth University Medical Center

A clinical research study of CDX-301 with or without plerixafor

Richmond : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Richmond : Virginia Cancer Institute

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Roanoke : Blue Ridge Cancer Care

A clinical research study for the treatment of Chronic Myeloid Leukemia

Roanoke : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Roanoke

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Salem : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Salem

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Winchester : US Oncology - Shenandoah Oncology - Winchester

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Woodbridge : US Oncology - Fairfax - Northern Virginia Hem-Onc, PC - Woodbridge

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Wytheville : US Oncology - Onc and Hem Assoc of Southwest VA, Inc - Wytheville

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Washington

Bellingham : PeaceHealth St Joseph Cancer Center

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Bellingham : Peace Health Medical Group

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Edmonds : US Oncology - Puget Sound Cancer Center - Edmonds

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Everett : Providence Everett Medical Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kennewick : Columbia Basin Hematology and Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Kennewick : Columbia Basin Hematology and Oncology

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Seattle : Fred Hutchinson Cancer Research Center Oncology

A clinical research study of Midostaurin (PKC412) and Standard of Care for the treatment of Acute Myeloid Leukemia

Seattle : Seattle Children's Hospital

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Seattle : Seattle Cancer Care Alliance

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

Seattle : Seattle Children's Hospital

A clinical trial to evaluate treatments for patients with Acute Lymphoblastic Leukemia

Seattle : US Oncology - Puget Sound Cancer Center - Seattle

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Seattle : Site Reference ID/Investigator# 52882

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Seattle : Research Site

A clinical trial to evaluate treatments using AMG 232 for patients with Acute Myeloid Leukemia

Seattle : Fred Hutchinson Cancer Research Center

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Seattle : Seattle Cancer Care Alliance

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Seattle : University of Washington

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Seattle : Fred Hutchinson Cancer Research Center Updated

A clinical trial to evaluate treatments using Oral Azacitidine for patients with Leukemia, Myeloid, Acute or Myelodysplastic Syndromes

Seattle : Fred Hutchinson Cancer Research Center

A clinical trial to evaluate treatments using PLX3397 for patients with Acute Myeloid Leukemia

Seattle : Seattle Cancer Care Alliance

A clinical trial to evaluate treatments using Vincristine Sulfate Liposomes Injection (VSLI) and Vincristine Sulfate Injection (VSI) for patients with Acute Lymphoblastic Leukemia (ALL)

Seattle : University of Washington

A Phase 1 clinical study for patients with Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Seattle : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Seattle : Pfizer Investigational Site

A Phase 1/Phase 2 clinical study for patients with Acute Myeloid Leukemia

Seattle : Swedish Cancer Institute

A Phase 3 clinical study for patients with AML

Seattle : Seattle Children's Hospital Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Seattle : Virginia Mason Medical Center

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Seattle : Fred Hutchinson Cancer Research Center

Patients are needed to participate in a clinical research study evaluating CWP232291 for the treatment of Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome or Myelofibrosis

Seattle : University of Washington

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Seattle :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Seattle : Fred Hutchinson Cancer Research Center

Patients are needed to participate in a clinical research study of RGI-2001 to evaluate Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT

Seattle : Fred Hutchinson Cancer Research Center

Patients are needed to participate in a clinical research study of SGN-CD33A to evaluate Acute Myelogenous Leukemia or Acute Myeloid Leukemia

Seattle : Seattle Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Spokane : Providence Cancer Center at Sacred Heart Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Spokane : Medical Oncology Associates PS

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spokane : US Oncology - Cancer Care Northwest - Sherman

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spokane : US Oncology - Cancer Care Northwest - Holland

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Spokane : US Oncology - Cancer Care Northwest - Mission

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Tacoma :

A Phase 1 clinical study for patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Tacoma : Multicare Research Institute

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 134th St

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Vancouver : US Oncology - Northwest Cancer Specialists, PC - Vancouver - 136th St.

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Vancouver : Northwest Cancer Specialists, PC

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Walla Walla : Providence St. Mary Regional Cancer Center

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Wenatchee : Wenatchee Valley Medical Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Wenatchee : Wenatchee Valley Medical Center

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Yakima : Yakima Valley Memorial Hospital/North Star Lodge

A clinical research study for the treatment of Chronic Myeloid Leukemia

Yakima : US Oncology - Yakima Valley Memorial Hospital/North Star Lodge (Boyd)

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Yakima :

A clinical trial to evaluate treatments using GDC-0199 (ABT-199), rituximab [MabThera/Rituxan] and bendamustine for patients with Lymphocytic Leukemia, Chronic

Yakima : Yakima Valley Memorial Hospital North Star Lodge

Patients are needed to participate in a clinical research study evaluating GS-9973 for the treatment of Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma or Indolent Non-Hodgkin's Lymphoma

Yakima : Yakima Valley Memorial Hospital/North Star Lodge

Patients are needed to participate in a clinical research study evaluating Sotatercept 0.1 mg/kg, Sotatercept 0.3 mg/kg and Sotatercept 0.5 mg/kg for the treatment of Anemia, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Low to Intermediate-1 MDS

West Virginia

Morgantown : West Virginia University - Clinical Trials Research Unit

B1931022 - An Open-label, Randomized Phase 3 Study of Inotuzumab Ozogamicin Compared to a Defined Investigator's Choice in Adult Patients with Relapsed or Refractory CD22-Positive Acute Lymphoblastic Leukemia (ALL)

Morgantown : West Virginia University - Clinical Trials Research Unit

BMTCTN1101: A Multi-Center, Phase III, Randomized Trial of Reduced Intensity (RIC) Conditioning and Transplantation of Double Unrelated Umbilical Cord Blood (dUCB) versus HLA-Haploidentical Related Bone Marrow (haplo-BM) for Patients with Hematologic Malignancies

Morgantown : West Virginia University - Clinical Trials Research Unit

CASE 1908: A Phase I/II Study of Midostaruin(PKC412) and 5-Azaacitidine for Elderly Patients with Acute Myelogenous Leukemia

Morgantown : West Virginia University - Clinical Trials Research Unit

E2906- Phase III trial of Clofarabine as induction and post-remission therapy vs. standard daunorubicin & cytarabine post-remission therapy, followed by decitabine maintenance vs. observation in newly-diagnosed Acute Myeloid Leukemia in older adults (age greater than or equal to 60 years)

Huntington : Edwards Comprehensive Cancer Center-University Oncology Services

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Huntington : St. Mary's Medical Center

A Phase 4 clinical study for patients with Chronic Myelogenous Leukemia in Chronic Phase

Martinsburg : City Hospital - West Virginia University Hospital East

A clinical research study for the treatment of Chronic Myeloid Leukemia

Morgantown : West Virginia University Hospitals

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Morgantown : West Virginia University Hospitals Pharmaceutical Services

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Morgantown : West Virginia University

A Phase 2 clinical study for patients using Plerixafor

Wheeling : Wheeling Hospital

A clinical research study for the treatment of Chronic Myeloid Leukemia

Wisconsin

Green Bay : St. Vincent Hospital

A clinical study for patients with Myelodysplastic Syndromes or Acute Myeloid Leukemia

Green Bay : St. Vincent Hospital/Green Bay Oncology

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Green Bay : Green Bay Oncology

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Madison : Site Reference ID/Investigator# 56811

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Milwaukee : Medical College of Wisconsin

A clinical research study of Panobinostat and Cytarabine for the treatment of Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood, Hodgkin's Disease or Non-Hodgkin's Lymphoma

Milwaukee : Medical College of Wisconsin

A Phase 2 clinical study for patients using Plerixafor

Milwaukee : Froedtert-Medical College Of Wisconsin

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Milwaukee : Midwest Children's Cancer Center Updated

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Milwaukee : Froedtert Hospital and the Medical College of Wisconsin

Patients are needed to participate in a clinical research study evaluating Bosutinib and Imatinib for the treatment of Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

Milwaukee : Aurora Research Institute Aurora Health Care

Patients are needed to participate in a clinical research study evaluating LEE011 for the treatment of Tumors With CDK4/6 Pathway Activation

Milwaukee : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Milwaukee : The Medical College of Wisconsin

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Milwaukee : Medical College of Wisconsin

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Waukesha : Waukesha Memorial Hospital

A clinical trial to evaluate treatments for patients with Chronic Lymphocytic Leukemia

Wausau : Aspirus Regional Cancer Center

A clinical research study for the treatment of Chronic Myeloid Leukemia

Argentina

Buenos Aires : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Buenos Aires : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Caba : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Capital Federal : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Cordoba : Sanatorio Allende

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

La Plata : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

San Miguel de Tucuman : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Santa Fé : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia

Australia

Adelaide : Local Institution

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Adelaide : Royal Adelaide Hospital

A clinical trial seeking patients for a research study for the treatment of Chronic Myeloid Leukaemia

Adelaide : Haematology and Bone Marrow Transplant Unit, Royal Adelaide Hospital

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Adelaide :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Adelaide : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Adelaide : Novartis Investigative Site

A Phase 1 clinical study for patients with Chronic Myelogenous Leukemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Adelaide : Royal Adelaide Hospital

A Phase 3 clinical study for patients with AML

Adelaide : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Adelaide : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Adelaide : IMVS

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Australia : Westmead Hospital

A Phase 3 clinical study for patients with AML

Bedford Park : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Bedford Park : Flinders Medical Centre, Department of Haematology, Level 6

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Bedford Park : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Bedford Park : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Box Hill : Eastern Clinical Research Unit

A clinical trial to evaluate treatments using inotuzumab ozogamicin, FLAG (fludarabine, cytarabine and G-CSF), HIDAC (high dose cytarabine) and cytarabine and mitoxantrone for patients with Acute Lymphoblastic Leukemia

Box Hill : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Box Hill : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Brisbane : Site Reference ID/Investigator# 98837

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Brisbane : The Princess Alexandra Hospital

A Phase 3 clinical study for patients with AML

Brisbane : Royal Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Camperdown : Royal Prince Alfred Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Canberra : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Clayton : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Clayton : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Coburg : Site Reference ID/Investigator# 98835

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Concord :

A clinical research study of Rituximab and Ibrutinib for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Concord : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Concord : Concord Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Douglas : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

East Melbourne : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

East Melbourne : Site Reference ID/Investigator# 48323

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

East Melbourne : Site Reference ID/Investigator# 91795

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

East Melbourne : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

East Melbourne : Updated

Patients are needed to participate in a clinical research study evaluating RO5503781 and cytarabine for the treatment of Myelogenous Leukemia, Acute

East Melbourne :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Fitzroy : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Fitzroy : St. Vincent's Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Frankston : Frankston Hospital

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Frankston : Frankston Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Freemantle :

A clinical research study of Rituximab and Ibrutinib for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Garran : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Gosford :

A clinical research study of Rituximab and Ibrutinib for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Heidelberg :

A clinical research study of Rituximab and Ibrutinib for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Herston : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Hobart : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Kingswood : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Kingswood : Nepean Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Kogarah : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Kogarah : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Kogarah : The St. George Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Kogarah, New South Wales : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Kurralta Park : Ashford Cancer Centre Research

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Liverpool : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Melbourne : GSK Investigational Site

A clinical trial seeking patients for a Leukemia treatment research study

Melbourne : Box Hill Hospital, Eastern Health

A Phase 2 clinical study for patients with Acute Myeloid Leukemia

Melbourne : Alfred Hospital

A Phase 3 clinical study for patients with AML

Melbourne : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Melbourne : Royal Children's Hospital, Melbourne

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Nedlands : Novartis Investigative Site Updated

A clinical trial to evaluate treatments using Nilotinib for patients with Philidelphia Positive Chronic Myeloid Leukaemia

Nedlands :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Nedlands : Sir Charles Gairdner Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

North Gosford : Jarrett Street Specialist Centre

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Parkville : Local Institution

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

Parkville : Royal Melbourne Hospital

A clinical trial seeking patients for a research study for the treatment of Leukemia, Myeloid, Acute

Parkville : Site Reference ID/Investigator# 48322

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia or Non-Hodgkin Lymphoma

Parkville : Site Reference ID/Investigator# 91794

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

Parkville : Royal Melbourne Hospital

A Phase 3 clinical study for patients with AML

Parkville : GSK Investigational Site

Patients are needed to participate in a clinical research study evaluating Daunorubicin, Cytarabine, Eltrombopag and Placebo for the treatment of Leukaemia, Acute

Parkville : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Parkville : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Perth : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Prahran :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Prahran : Novartis Investigative Site

A Phase 1 clinical study for patients with Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)

Prahran : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Queensland :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Randwick : The Sydney Children's Hospital, Centre for Children's Cancer and Blood Disorders

Patients are needed to participate in a clinical research study to evaluate Leukemia

St Leonards : Local Institution

A clinical research study of Dasatinib and Nivolumab for the treatment of Chronic Myeloid Leukemia

St Leonards : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

St. Leonards : Site Reference ID/Investigator# 98836

A clinical trial to evaluate treatments using ABT-199 for patients with Chronic Lymphocytic Leukemia, 17 p Deletion or Cancer of the Blood and Bone Marrow

St. Leonards : Royal North Shore Hospital

Patients are needed to participate in a clinical research study of Lenalidomide and Placebo to evaluate B-cell Chronic Lymphocytic Leukemia

Sydney : Sydney Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Tweed Heads :

A clinical research study of Rituximab and Ibrutinib for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Waratah : Calvary Mater Newcastle

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Westmead :

A clinical trial to evaluate treatments using KB004, Monoclonal Antibody for patients

Westmead : The Children's Hospital at Westmead, Department of Oncology

Patients are needed to participate in a clinical research study to evaluate Leukemia

Westmead, NSW : Children's Hospital at Westmead

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Woodend : Canberra Hospital and Health Services

A Phase 3 clinical study for patients with AML

Woodville : The Queen Elizabeth Hospital

A Phase 3 clinical study for patients with AML

Woodville South : Queen Elizabeth Hospital

A clinical trial to evaluate treatments using Idelalisib, Bendamustine, Rituximab and Idelalisib placebo for patients with Chronic Lymphocytic Leukemia

Woolloongabba : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Woolloongabba :

Patients are needed to participate in a clinical research study of GDC-0853 to evaluate Lymphoma, B-Cell, Lymphocytic Leukemia, Chronic

Austria

Dornbirn : Krankenhaus Dornbirn, Abt. für Kinder- und Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Furstenfeld : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Graz : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Graz : Univ.-Kinderklinik Graz, Abt. Pädiatrische Hämato-Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Innsbruck : Medizinische Universität Innsbruck

A Phase 2 clinical study for patients with Acute Myeloid Leukemia

Innsbruck : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Innsbruck : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Innsbruck : Studienambulanz Haematologie - Medizinische Universitaetsklinik

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Innsbruck : Department f. Kinder- u. Jugendheilkunde, Universitätsklinik f. Pädiatrie II

Patients are needed to participate in a clinical research study to evaluate Leukemia

Klagenfurt : A.oe. Landeskrankenhaus Klagenfurt, Abt. für Kinder- und Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Leoben : A.oe. Landeskrankenhaus Leoben, Abt. für Kinder und Jugendliche

Patients are needed to participate in a clinical research study to evaluate Leukemia

Linz : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Linz : Krankenhaus der Barmherzigen Schwestern Linz

A Phase 2 clinical study for patients with Acute Myeloid Leukemia

Linz : Krankenhaus der Elisabethinen Linz GmbH

A Phase 2 clinical study for patients with Acute Myeloid Leukemia

Linz : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Linz : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Linz : Elisabethinen Krankenhaus

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Linz : Landes-Kinderklinik Linz, Haematologie/Onkologie

Patients are needed to participate in a clinical research study to evaluate Leukemia

Salzburg : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Salzburg : Universitätsklinik für Innere Medizin III Salzburg

A Phase 2 clinical study for patients with Acute Myeloid Leukemia

Salzburg : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Salzburg : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Salzburg : Onkologische Tagesklinik - Univ. Klinik fur Innere Medizin III - LKH

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Salzburg : St. Johanns Spital / Landeskrankenhaus, Salzburg, Kinderspital Abt. Kinder u. Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Vienna : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Vienna : Novartis Investigative Site Updated

A clinical trial seeking pediatric patients for a research study of nilotinib for Chronic Myelogenous Leukemia (CML)

Vienna : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Vienna : St. Anna Children's Hospital

Patients are needed to participate in a clinical research study to evaluate Relapsed T-Cell Acute Lymphoblastic Leukemia or Relapsed T-Cell Lymphoblastic Lymphoma

Wels : Updated

A clinical trial seeking patients for a research study for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Wels : Local Institution

A Phase 2 clinical study for patients with Chronic Phase Chronic Myeloid Leukemia

Wels : Updated

Patients are needed to participate in a clinical research study evaluating IPI-145 and Ofatumumab for the treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Wels : Klinikum Wels-Grieskirchen GmbH, IV. Interne Abteilung

Patients are needed to participate in a clinical research study evaluating P1101 for the treatment of Chronic Phase Chronic Myeloid Leukemia

Wels : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Wels : Klinikum Wels-Grieskirchen GmbH

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Wien : 1230.27.43001 Boehringer Ingelheim Investigational Site Updated

A clinical trial seeking patients for a research study for the treatment of Leukemia or Neoplasms

Wien : Novartis Investigative Site

A clinical trial seeking patients for a research study for the treatment of Myelogenous Leukemia, Chronic

Wien : Hanuschkrankenhaus Wien

A Phase 2 clinical study for patients with Acute Myeloid Leukemia

Wien : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Wien : Updated

Patients are needed to participate in a clinical research study evaluating GDC-0199, Rituximab [MabThera/Rituxan] and Bendamustine for the treatment of Chronic Lymphocytic Leukemia

Wien : Research Site

Patients are needed to participate in a clinical research study evaluating Other: not applicable - observational study for the treatment of B-cell Precursor Acute Lymphoblastic Leukemia (ALL)

Wien : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Wien : Research Site

Patients are needed to participate in a clinical research study of Blinatumomab and Standard of Care Chemotherapy to evaluate Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia

Wien : Hanusch Krankenhaus

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Wien : AKH Wien / MedUni Wien

Patients are needed to participate in a clinical research study of Sapacitabine and decitabine and Decitabine to evaluate Acute Myeloid Leukemia

Wien : St. Anna Kinderspital, Zentrum für Kinder- und Jugendheilkunde

Patients are needed to participate in a clinical research study to evaluate Leukemia

Belgium